KR20240068807A - Method for manufacturing yuzu enzyme reactant with reduced bitterness and health functional food composition for diet comprising the same - Google Patents
Method for manufacturing yuzu enzyme reactant with reduced bitterness and health functional food composition for diet comprising the same Download PDFInfo
- Publication number
- KR20240068807A KR20240068807A KR1020220141299A KR20220141299A KR20240068807A KR 20240068807 A KR20240068807 A KR 20240068807A KR 1020220141299 A KR1020220141299 A KR 1020220141299A KR 20220141299 A KR20220141299 A KR 20220141299A KR 20240068807 A KR20240068807 A KR 20240068807A
- Authority
- KR
- South Korea
- Prior art keywords
- citron
- enzyme
- strain
- group
- culture supernatant
- Prior art date
Links
- 235000019658 bitter taste Nutrition 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 230000002829 reductive effect Effects 0.000 title claims abstract description 39
- 230000036541 health Effects 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 23
- 235000013376 functional food Nutrition 0.000 title claims abstract description 22
- 235000005911 diet Nutrition 0.000 title claims abstract description 21
- 230000037213 diet Effects 0.000 title claims abstract description 21
- 102000004190 Enzymes Human genes 0.000 title claims description 109
- 108090000790 Enzymes Proteins 0.000 title claims description 109
- 238000000034 method Methods 0.000 title claims description 11
- 239000000376 reactant Substances 0.000 title claims 3
- 241000951471 Citrus junos Species 0.000 title description 10
- 240000004307 Citrus medica Species 0.000 claims abstract description 195
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 52
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 28
- 229940088598 enzyme Drugs 0.000 claims description 108
- 239000012228 culture supernatant Substances 0.000 claims description 74
- 238000006243 chemical reaction Methods 0.000 claims description 52
- 239000000843 powder Substances 0.000 claims description 35
- 239000000758 substrate Substances 0.000 claims description 33
- 241000228245 Aspergillus niger Species 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 240000006439 Aspergillus oryzae Species 0.000 claims description 19
- 241000228212 Aspergillus Species 0.000 claims description 18
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 18
- 235000000346 sugar Nutrition 0.000 claims description 17
- 244000207740 Lemna minor Species 0.000 claims description 11
- 235000006439 Lemna minor Nutrition 0.000 claims description 11
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 11
- 108010047754 beta-Glucosidase Proteins 0.000 claims description 11
- 102000006995 beta-Glucosidase Human genes 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 11
- 235000013399 edible fruits Nutrition 0.000 claims description 11
- 108010002430 hemicellulase Proteins 0.000 claims description 11
- 229940059442 hemicellulase Drugs 0.000 claims description 11
- 108010059892 Cellulase Proteins 0.000 claims description 10
- 229940106157 cellulase Drugs 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 230000008961 swelling Effects 0.000 claims description 10
- 108091005804 Peptidases Proteins 0.000 claims description 9
- 239000004365 Protease Substances 0.000 claims description 9
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 241000272525 Anas platyrhynchos Species 0.000 claims description 7
- 235000013325 dietary fiber Nutrition 0.000 abstract description 25
- 230000004130 lipolysis Effects 0.000 abstract description 12
- 239000002245 particle Substances 0.000 abstract description 12
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 239000006185 dispersion Substances 0.000 abstract description 9
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 61
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 61
- 229930019673 naringin Natural products 0.000 description 61
- 229940052490 naringin Drugs 0.000 description 61
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 48
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 46
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 41
- 239000000243 solution Substances 0.000 description 30
- 238000004458 analytical method Methods 0.000 description 19
- 239000003925 fat Substances 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 17
- 229920002488 Hemicellulose Polymers 0.000 description 15
- 230000004069 differentiation Effects 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- 239000001913 cellulose Substances 0.000 description 12
- 229920002678 cellulose Polymers 0.000 description 12
- 239000001814 pectin Substances 0.000 description 12
- 229920001277 pectin Polymers 0.000 description 12
- 235000010987 pectin Nutrition 0.000 description 12
- 230000035484 reaction time Effects 0.000 description 12
- 210000001789 adipocyte Anatomy 0.000 description 11
- 229920005610 lignin Polymers 0.000 description 11
- 238000000354 decomposition reaction Methods 0.000 description 10
- 238000004809 thin layer chromatography Methods 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 235000020971 citrus fruits Nutrition 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 230000007935 neutral effect Effects 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 210000000229 preadipocyte Anatomy 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 7
- 108010039731 Fatty Acid Synthases Proteins 0.000 description 7
- 235000008504 concentrate Nutrition 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 6
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 6
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 6
- 230000003013 cytotoxicity Effects 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 230000004132 lipogenesis Effects 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 108010001078 naringinase Proteins 0.000 description 6
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 5
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 5
- 108010059820 Polygalacturonase Proteins 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 229940030275 epigallocatechin gallate Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 241000208340 Araliaceae Species 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000013256 coordination polymer Substances 0.000 description 4
- -1 flavonoid compounds Chemical class 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000001916 dieting Nutrition 0.000 description 3
- 230000037228 dieting effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 2
- 241000228215 Aspergillus aculeatus Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 101100114416 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) con-10 gene Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000011166 aliquoting Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 229940025878 hesperidin Drugs 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 2
- 229940117954 naringenin Drugs 0.000 description 2
- 235000007625 naringenin Nutrition 0.000 description 2
- DLIKSSGEMUFQOK-SFTVRKLSSA-N naringenin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C(C(=O)C[C@H](O2)C=3C=CC(O)=CC=3)C2=C1 DLIKSSGEMUFQOK-SFTVRKLSSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- RXVLWCCRHSJBJV-UHFFFAOYSA-N prunin Natural products OCC1OC(O)C(Oc2cc(O)c3C(=O)CC(Oc3c2)c4ccc(O)cc4)C(O)C1O RXVLWCCRHSJBJV-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 235000019583 umami taste Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- OBMBUODDCOAJQP-UHFFFAOYSA-N 2-chloro-4-phenylquinoline Chemical compound C=12C=CC=CC2=NC(Cl)=CC=1C1=CC=CC=C1 OBMBUODDCOAJQP-UHFFFAOYSA-N 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 101001000135 Arabidopsis thaliana Polygalacturonase 1 beta-like protein 1 Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241001660788 Cinchona calisaya Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- 101001097860 Lithospermum erythrorhizon Phenylalanine ammonia-lyase 1 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 238000007476 Maximum Likelihood Methods 0.000 description 1
- NULAJYZBOLVQPQ-UHFFFAOYSA-N N-(1-naphthyl)ethylenediamine Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1 NULAJYZBOLVQPQ-UHFFFAOYSA-N 0.000 description 1
- ZIKZPLSIAVHITA-UHFFFAOYSA-N Nomilinic acid Natural products CC(=O)OC(CC(O)=O)C1(C)C(C(C)(C)O)CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 ZIKZPLSIAVHITA-UHFFFAOYSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 108010029182 Pectin lyase Proteins 0.000 description 1
- 101710089302 Polygalacturonase-2 Proteins 0.000 description 1
- 239000012083 RIPA buffer Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000223262 Trichoderma longibrachiatum Species 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000011759 adipose tissue development Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000012152 bradford reagent Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 238000000445 field-emission scanning electron microscopy Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 150000002630 limonoids Chemical class 0.000 description 1
- 230000003520 lipogenic effect Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- KPDOJFFZKAUIOE-WNGDLQANSA-N nomilin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@H]2C(C)(C)OC(=O)C[C@@H]([C@]42C)OC(=O)C)C=COC=1 KPDOJFFZKAUIOE-WNGDLQANSA-N 0.000 description 1
- KPDOJFFZKAUIOE-HPFWCIFASA-N nomilin Natural products O=C(O[C@H]1[C@@]2(C)[C@@H](C(C)(C)OC(=O)C1)CC(=O)[C@]1(C)[C@@H]2CC[C@@]2(C)[C@H](c3cocc3)OC(=O)[C@@H]3O[C@@]123)C KPDOJFFZKAUIOE-HPFWCIFASA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000002420 orchard Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000003921 particle size analysis Methods 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 108020004410 pectinesterase Proteins 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 150000003214 pyranose derivatives Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
- A23L2/06—Extraction of juices from citrus fruits
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/08—Concentrating or drying of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/10—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/18—Fractionation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/66—Aspergillus
- C12R2001/685—Aspergillus niger
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/66—Aspergillus
- C12R2001/69—Aspergillus oryzae
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
본 발명은 쓴맛이 저감된 유자 효소반응물의 제조 방법 및 이를 포함하는 다이어트용 건강기능식품 조성물에 관한 것으로서, 상기 유자 효소반응물은 유자 고유의 쓴맛이 효과적으로 감소하였을 뿐만 아니라 입자의 크기가 줄어 용해도가 향상되고 균일도와 분산도 또한 상승하였으며, 이로부터 분리된 식이섬유는 지방 생성 억제 또는 지방 분해 촉진에 유용할 것으로 예상되므로, 이를 효과적으로 다이어트용 건강기능식품 조성물의 제조에 이용할 수 있다.The present invention relates to a method for producing a citron enzyme reaction with reduced bitterness and a health functional food composition for diet containing the same. The citron enzyme reaction product not only effectively reduces the inherent bitterness of citron, but also improves solubility by reducing particle size. The uniformity and dispersion also increased, and the dietary fiber isolated from this is expected to be useful in suppressing fat production or promoting lipolysis, so it can be effectively used in the production of a health functional food composition for diet.
Description
본 발명은 쓴맛이 저감된 유자 효소반응물의 제조 방법 및 이를 포함하는 다이어트용 건강기능식품 조성물에 관한 것으로서, 더욱 상세하게는 유자를 포함하는 기질조성물에 아스퍼질러스 나이거(Aspergillus niger) 유래 효소 또는 아스퍼질러스 오리재(Aspergillus oryzae) 균주 배양 상등액을 반응시켜 쓴맛이 저감된 유자 효소반응물을 제조하는 방법 및 이를 포함하는 다이어트용 건강기능식품 조성물에 관한 것이다.The present invention relates to a method for producing a citron enzyme reaction with reduced bitterness and a health functional food composition for diet containing the same, and more specifically, to a substrate composition containing citron, an enzyme derived from Aspergillus niger or The present invention relates to a method for producing a citron enzyme reaction product with reduced bitterness by reacting Aspergillus oryzae strain culture supernatant and a health functional food composition for diet containing the same.
유자는 우리나라 남해안의 유일한 특산물로, 거제도를 중심으로 연간 약 2만톤 정도 생산되는 것으로 추정된다. 현재는 유자가 과잉 생산되고 있어 농가에서는 거의 재배를 포기한 상태이며, 지금까지 가공 생산하여 오던 유자청(유자차 용)도 계절적으로 겨울철에 한하여 소비되고 여름 동안은 저장이 되지 않아 막대한 양이 폐기처분되고 있는 실정이다.Citron is the only specialty product of Korea's southern coast, and is estimated to be produced annually around 20,000 tons, mainly on Geoje Island. Currently, citron is overproduced and farms have almost given up on growing it, and the citron syrup (for citron tea) that has been processed and produced so far is only consumed seasonally in the winter and cannot be stored during the summer, so a huge amount is being discarded. This is the situation.
유자는 비타민 C, P 및 E가 풍부할 뿐만 아니라, 현재 미국과 일본 등지에서 자몽과 오렌지류에서 발견되어 강력한 항암 물질로 밝혀지고 있는 리모노이드(limonoid) 계통의 화합물인 리모닌(limonin) 및 노밀린(nomilin)이 상당히 많은 양이 들어있음이 확인되었다. 특히 항암력이 높은 리모넨(limonene)을 비롯한 카로본(carvone), 코마린(coumarin), 테르피넨(terpinene)과 같은 플라보노이드(flavonoid) 계통의 화합물도 다량 함유되어 있음이 밝혀졌다. 유자는 주로 껍질 속에 이러한 생리활성물질이 다량 함유되어 있으므로 껍질을 반드시 먹어야 하는 과일이다.Yuzu is not only rich in vitamins C, P, and E, but also contains limonin and citron, a compound of the limonoid family that is currently found in grapefruits and oranges in the United States and Japan and has been shown to be a powerful anti-cancer substance. It was confirmed that nomilin was contained in a significant amount. In particular, it was found that it contains a large amount of flavonoid compounds such as limonene, carvone, coumarin, and terpinene, which have high anti-cancer properties. Citron is a fruit that must be eaten with its peel because the peel contains a large amount of these bioactive substances.
현재까지 유자는 주로 유자청으로 이용되었고 설탕 약 60%에 세절한 유자를 절여 두었다가 일정량을 물에 타서 차로 이용하는 것이 전부였다. 최근 일부 회사에서 판매하고 있는 유자 주스도 유자청에 물을 가하여 착즙하거나 유자를 압착하여 짠 유자액을 물로 희석하여 만든 것으로, 껍질의 유효 생리활성물질이 거의 이용되지 못하는 실정이다.Until now, citrons were mainly used as citron syrup, and the only way to do this was to pickle finely chopped citrons in about 60% sugar, add a certain amount of water, and use it as tea. Recently, citron juice sold by some companies is made by adding water to citron extract or diluting citron juice squeezed by pressing citron with water, so the effective bioactive substances in the peel are hardly utilized.
유자의 쓴맛의 주성분은 나린진(naringin) 및 헤스페리딘(hesperidin)인데 다른 감귤류에 비하여 다량 함유되어 있다. 유자는 과실이 익어도 타 감귤류와는 달리 이들 쓴맛 성분을 분해하는 나린진아제(naringinase) 효소가 없기 때문에 쓴맛을 그대로 갖고 있는 것이 특징이며, 또한 펙틴의 함량이 타 감귤류의 3배 이상 함유하고 있어 생과를 껍질째 주스화 하기는 불가능하였다. 유자청 제조 시 쓴맛을 제거하기 위하여 과실 총량의 60% 이상의 설탕을 넣어 절여 만든다. 그러므로 과도한 양의 설탕 단맛이 나린진의 쓴맛을 차폐하여 쓴맛을 덜 느끼게 된다. 현재로서는 생산되는 유자의 대부분이 유자청으로 소비되므로 과도한 양의 설탕을 섭취하게 되며 유자청 중의 유자 껍질은 대부분 먹지 않고 버려지고 있다.The main components of yuzu's bitter taste are naringin and hesperidin, which are contained in large amounts compared to other citrus fruits. Even when the fruit is ripe, citron retains its bitter taste because, unlike other citrus fruits, it does not have the naringinase enzyme that breaks down these bitter substances. Additionally, it contains more than three times the pectin content of other citrus fruits, making it a fresh fruit. It was impossible to juice it with the skin. When making yujacheong, it is made by pickling it with more than 60% of the total amount of sugar to remove the bitter taste. Therefore, the excessive amount of sugar sweetness masks the bitter taste of naringin, making it less bitter. Currently, most of the citron produced is consumed as citron syrup, which results in excessive amounts of sugar being consumed, and most of the citron peels in the citron syrup are discarded without being eaten.
일부 감귤류, 특히 유자에 존재하는 쓴맛은 과량으로 존재하여 유자주스 제조에 제약이 된다. 또한 인삼에 있어서도 강한 쓴맛 때문에 인삼 음료가 어린이를 비롯한 대중들의 기호음료가 되지 못하고 있다. 따라서 감귤류와 인삼의 쓴맛을 제거하여 음료를 만드는 것은 감귤류 음료나 인삼 음료를 대중화시키는 데 있어서 상업적으로 매우 유용하다.The bitter taste present in some citrus fruits, especially yuzu, is present in excessive amounts and is a limitation in the production of yuzu juice. Also, due to the strong bitter taste of ginseng, ginseng drinks are not becoming a favorite beverage for the public, including children. Therefore, making drinks by removing the bitter taste of citrus fruits and ginseng is very commercially useful in popularizing citrus drinks and ginseng drinks.
유자의 쓴맛을 제거하는 나린진아제(naringinase)효소를 생산하기 위해서는 곰팡이 배양액의 제조방법이 연구되어 왔다. 나린진아제 생성 균주는 배양시 나린진아제 외에 베타-글루코시다제(beta-glucosidase) 효소도 같이 생성하는 것으로 알려져 있다. 유자의 쓴맛이 제거되는 기작은 베타-글루코시다제와 나린진아제가 단계적으로 작용하여 쓴맛을 내는 나린진을 쓴맛이 없는 프루닌(prunin)과 나린제닌(naringenin)으로 분해하기 때문으로 알려져 있다.Methods for producing fungal cultures have been studied to produce naringinase enzyme, which removes the bitter taste of citron. Naringinase-producing strains are known to produce beta-glucosidase enzyme in addition to naringinase during culture. It is known that the mechanism by which the bitter taste of citron is removed is because beta-glucosidase and naringinase work step by step to decompose naringin, which produces a bitter taste, into prunin and naringenin, which do not have a bitter taste.
이에 본 발명자들은 유자를 포함하는 기질조성물에 아스퍼질러스 나이거(Aspergillus niger) 유래 효소 또는 아스퍼질러스 오리재(Aspergillus oryzae) 균주 배양 상등액을 반응시키는 경우 유자 고유의 쓴맛이 효과적으로 저감되고, 이로부터 제조된 식이섬유에서 지방 생성 억제 효과 및 지방 분해 촉진 효과가 발휘되며, 수분보유력(Water holding capacity; WHC), 유지보유력(Oil holding capacity; OHC), 팽윤력(swelling capacity; SC) 및 용해도가 증가한 것을 확인하였다.Accordingly, the present inventors found that when a substrate composition containing citron is reacted with an enzyme derived from Aspergillus niger or an Aspergillus oryzae strain culture supernatant, the inherent bitter taste of citron is effectively reduced. The manufactured dietary fiber has an effect of suppressing fat production and promoting lipolysis, and water holding capacity (WHC), oil holding capacity (OHC), swelling capacity (SC), and solubility are increased. confirmed.
이에, 본 발명의 목적은 유자를 포함하는 기질조성물에 아스퍼질러스 나이거 또는 아스퍼질러스 오리재 균주, 상기 균주의 배양물, 상기 배양물의 농축물, 상기 배양물의 건조물, 상기 균주의 배양 상등액 및 상기 배양 상등액의 분획물로 이루어진 군으로부터 선택된 1종 이상을 포함하는 반응 용액을 접촉시키는 반응 단계를 포함하는 쓴맛이 저감된 유자 효소반응물의 제조 방법을 제공하는 것이다.Accordingly, the object of the present invention is to provide a substrate composition containing citron, an Aspergillus niger or Aspergillus duckweed strain, a culture of the strain, a concentrate of the culture, a dried product of the culture, a culture supernatant of the strain, and To provide a method for producing a citron enzyme reaction with reduced bitterness, which includes a reaction step of contacting a reaction solution containing at least one selected from the group consisting of fractions of the culture supernatant.
본 발명의 다른 목적은 유자를 포함하는 기질조성물에 아스퍼질러스 나이거 또는 아스퍼질러스 오리재 균주, 상기 균주의 배양물, 상기 배양물의 농축물, 상기 배양물의 건조물, 상기 균주의 배양 상등액 및 상기 배양 상등액의 분획물로 이루어진 군으로부터 선택된 1종 이상을 포함하는 반응 용액을 반응시켜 제조된, 쓴맛이 저감된 유자 효소반응물을 포함하는 다이어트용 건강기능식품 조성물을 제공하는 것이다.Another object of the present invention is to provide a substrate composition containing citron, an Aspergillus niger or Aspergillus duckweed strain, a culture of the strain, a concentrate of the culture, a dried product of the culture, a culture supernatant of the strain, and the above. The present invention provides a health functional food composition for diet containing a citron enzyme reaction product with reduced bitterness, prepared by reacting a reaction solution containing at least one selected from the group consisting of fractions of culture supernatants.
본 발명의 또 다른 목적은 유자를 포함하는 기질조성물에 아스퍼질러스 나이거 또는 아스퍼질러스 오리재 균주, 상기 균주의 배양물, 상기 배양물의 농축물, 상기 배양물의 건조물, 상기 균주의 배양 상등액 및 상기 배양 상등액의 분획물로 이루어진 군으로부터 선택된 1종 이상을 포함하는 반응 용액을 반응시켜 제조된, 쓴맛이 저감된 유자 효소반응물의 다이어트, 지방 생성 억제 또는 지방 분해 촉진 용도에 관한 것이다.Another object of the present invention is to provide a substrate composition containing citron, an Aspergillus niger or Aspergillus duckweed strain, a culture of the strain, a concentrate of the culture, a dried product of the culture, a culture supernatant of the strain, and It relates to the use of a citron enzyme reaction with reduced bitterness, prepared by reacting a reaction solution containing at least one selected from the group consisting of fractions of the culture supernatant, for dieting, suppressing fat production, or promoting lipolysis.
본 발명은 쓴맛이 저감된 유자 효소반응물의 제조 방법 및 이를 포함하는 다이어트용 건강기능식품 조성물에 관한 것으로, 본 발명에 따른 효소 반응에 의하여 제조된 유자 효소반응물은 쓴맛이 저감되고 이로부터 분리한 식이섬유는 다이어트, 지방 생성 억제 또는 지방 분해 촉진에 유용함을 나타낸다.The present invention relates to a method for producing a citron enzyme reaction product with reduced bitterness and a health functional food composition for diet containing the same. The citron enzyme reaction product prepared by the enzyme reaction according to the present invention has a reduced bitter taste and can be used as a diet separated therefrom. Fiber is useful for dieting, inhibiting fat production, or promoting fat breakdown.
본 발명자들은 유자를 포함하는 기질조성물에 아스퍼질러스 나이거(Aspergillus niger) 유래 효소 또는 아스퍼질러스 오리재(Aspergillus oryzae) 균주 배양 상등액을 반응시켜 유자 고유의 쓴맛이 저감된 유자 효소반응물을 제조하였고, 이로부터 제조된 식이섬유에서 지방 생성 억제 효과 및 지방 분해 촉진 효과가 발휘되며, 수분보유력(Water holding capacity; WHC), 유지보유력(Oil holding capacity; OHC), 팽윤력(swelling capacity; SC) 및 용해도가 증가한 것을 확인하였다.The present inventors reacted Aspergillus niger-derived enzyme or Aspergillus oryzae strain culture supernatant with a substrate composition containing citron to prepare a citron enzyme reaction product in which the inherent bitter taste of citron was reduced. , the dietary fiber produced from this exhibits the effect of suppressing fat production and promoting lipolysis, and has water holding capacity (WHC), oil holding capacity (OHC), swelling capacity (SC), and It was confirmed that solubility increased.
이하 본 발명을 더욱 자세히 설명하고자 한다.Hereinafter, the present invention will be described in more detail.
본 발명의 일 양태는 유자를 포함하는 기질조성물에 아스퍼질러스 나이거 또는 아스퍼질러스 오리재 균주, 상기 균주의 배양물, 상기 배양물의 농축물, 상기 배양물의 건조물, 상기 균주의 배양 상등액 및 상기 배양 상등액의 분획물로 이루어진 군으로부터 선택된 1종 이상을 포함하는 반응 용액을 접촉시키는 반응 단계를 포함하는 쓴맛이 저감된 유자 효소반응물의 제조 방법이다.One aspect of the present invention is a substrate composition containing citron, an Aspergillus niger or Aspergillus duckweed strain, a culture of the strain, a concentrate of the culture, a dried product of the culture, a culture supernatant of the strain, and the above. A method for producing a citron enzyme reaction with reduced bitterness, comprising a reaction step of contacting a reaction solution containing at least one selected from the group consisting of fractions of culture supernatants.
본 발명에 있어서 상기 유자는 당절임, 동결건조분말, 농축액 및 착즙액으로 이루어진 군으로부터 선택되는 1종 이상의 형태로 제공되는 것일 수 있다.In the present invention, the citron may be provided in one or more forms selected from the group consisting of pickled sugar, freeze-dried powder, concentrate, and juice.
본 발명에 있어서 상기 유자는 과실 전체, 과육 및 과피로 이루어진 군으로부터 선택되는 1종 이상인 것일 수 있다.In the present invention, the citron may be one or more types selected from the group consisting of the whole fruit, pulp, and skin.
본 발명에 있어서 상기 아스퍼질러스 나이거 균주의 배양 상등액은 β-글루코시데이즈(β-glucosidase), 셀룰레이즈(cellulase), 헤미셀룰레이즈(hemicellulase) 및 프로테이즈(protease)로 이루어진 군으로부터 선택되는 1종 이상을 포함하는 것일 수 있고, 예를 들어, β-글루코시데이즈, 셀룰레이즈, 헤미셀룰레이즈 및 프로테이즈를 모두 포함하는 것일 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the culture supernatant of the Aspergillus niger strain is selected from the group consisting of β-glucosidase, cellulase, hemicellulase, and protease. It may include one or more types, for example, β-glucosidase, cellulase, hemicellulase, and protease, but is not limited thereto.
본 발명에 있어서 상기 아스퍼질러스 오리재 균주는 수탁번호 KCTC14898BP로 기탁된 아스퍼질러스 오리재 NYO2 균주인 것일 수 있다.In the present invention, the Aspergillus duck material strain may be the Aspergillus duck material NYO2 strain deposited under the accession number KCTC14898BP.
본 발명에 있어서 상기 반응 용액의 농도는 전체 효소반응물에 대하여 0.01 내지 1.00%(v/v)인 것일 수 있다.In the present invention, the concentration of the reaction solution may be 0.01 to 1.00% (v/v) based on the total enzyme reaction product.
상기 반응 용액이 아스퍼질러스 나이거 균주의 배양 상등액의 분획물인 경우, 상기 배양 상등액의 분획물은 β-글루코시데이즈, 셀룰레이즈, 헤미셀룰레이즈 및 프로테이즈를 포함하는 것일 수 있고, 바람직하게는 상기 반응 용액의 농도는 전체 효소반응물에 대하여 0.02 내지 1.00%(v/v), 0.05 내지 1.00%(v/v), 0.08 내지 1.00%(v/v), 0.10 내지 1.00%(v/v), 0.01 내지 0.50%(v/v), 0.02 내지 0.50%(v/v), 0.05 내지 0.50%(v/v), 0.08 내지 0.50%(v/v), 0.10 내지 0.50%(v/v), 0.01 내지 0.20%(v/v), 0.02 내지 0.20%(v/v), 0.05 내지 0.20%(v/v), 0.08 내지 0.20%(v/v), 0.10 내지 0.20%(v/v), 0.01 내지 0.10%(v/v), 0.02 내지 0.10%(v/v), 또는 0.05 내지 0.10%(v/v)인 것일 수 있고, 예를 들어, 0.08 내지 0.20%(v/v)인 것일 수 있으나, 이에 한정되는 것은 아니다.When the reaction solution is a fraction of the culture supernatant of the Aspergillus niger strain, the fraction of the culture supernatant may include β-glucosidase, cellulase, hemicellulase, and protease, preferably The concentration of the reaction solution is 0.02 to 1.00% (v/v), 0.05 to 1.00% (v/v), 0.08 to 1.00% (v/v), 0.10 to 1.00% (v/v) based on the total enzyme reaction product. , 0.01 to 0.50% (v/v), 0.02 to 0.50% (v/v), 0.05 to 0.50% (v/v), 0.08 to 0.50% (v/v), 0.10 to 0.50% (v/v) , 0.01 to 0.20% (v/v), 0.02 to 0.20% (v/v), 0.05 to 0.20% (v/v), 0.08 to 0.20% (v/v), 0.10 to 0.20% (v/v) , may be 0.01 to 0.10% (v/v), 0.02 to 0.10% (v/v), or 0.05 to 0.10% (v/v), for example, 0.08 to 0.20% (v/v). It may be, but is not limited to this.
상기 반응 용액이 아스퍼질러스 오리재 균주의 배양 상등액인 경우, 바람직하게는 상기 반응 용액의 농도는 전체 효소반응물에 대하여 0.02 내지 1.00%(v/v), 0.05 내지 1.00%(v/v), 0.08 내지 1.00%(v/v), 0.10 내지 1.00%(v/v), 0.20 내지 1.00%(v/v), 0.50 내지 1.00%(v/v), 0.01 내지 0.80%(v/v), 0.02 내지 0.80%(v/v), 0.05 내지 0.80%(v/v), 0.08 내지 0.80%(v/v), 0.10 내지 0.80%(v/v), 0.20 내지 0.80%(v/v), 0.50 내지 0.80%(v/v), 0.01 내지 0.50%(v/v), 0.02 내지 0.50%(v/v), 0.05 내지 0.50%(v/v), 0.08 내지 0.50%(v/v), 또는 0.10 내지 0.50%(v/v)인 것일 수 있고, 예를 들어, 0.20 내지 0.50%(v/v)인 것일 수 있으나, 이에 한정되는 것은 아니다.When the reaction solution is a culture supernatant of Aspergillus oryzae strain, the concentration of the reaction solution is preferably 0.02 to 1.00% (v/v), 0.05 to 1.00% (v/v), based on the total enzyme reaction product. 0.08 to 1.00% (v/v), 0.10 to 1.00% (v/v), 0.20 to 1.00% (v/v), 0.50 to 1.00% (v/v), 0.01 to 0.80% (v/v), 0.02 to 0.80% (v/v), 0.05 to 0.80% (v/v), 0.08 to 0.80% (v/v), 0.10 to 0.80% (v/v), 0.20 to 0.80% (v/v), 0.50 to 0.80% (v/v), 0.01 to 0.50% (v/v), 0.02 to 0.50% (v/v), 0.05 to 0.50% (v/v), 0.08 to 0.50% (v/v), Alternatively, it may be 0.10 to 0.50% (v/v), for example, 0.20 to 0.50% (v/v), but is not limited thereto.
본 발명에 있어서 상기 기질조성물의 농도는 전체 효소반응물에 대하여 0.10 내지 15.00%(v/w)인 것일 수 있고, 바람직하게는 0.50 내지 15.00%(v/w), 1.00 내지 15.00%(v/w), 2.50 내지 15.00%(v/w), 5.00 내지 15.00%(v/w), 0.10 내지 10.00%(v/w), 0.50 내지 10.00%(v/w), 1.00 내지 10.00%(v/w), 2.50 내지 10.00%(v/w), 5.00 내지 10.00%(v/w), 0.10 내지 7.50%(v/w), 0.50 내지 7.50%(v/w), 1.00 내지 7.50%(v/w), 2.50 내지 7.50%(v/w), 5.00 내지 7.50%(v/w), 0.10 내지 5.00%(v/w), 0.50 내지 5.00%(v/w), 또는 1.00 내지 5.00%(v/w)인 것일 수 있고, 예를 들어, 2.50 내지 5.00%(v/w)인 것일 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the concentration of the substrate composition may be 0.10 to 15.00% (v/w), preferably 0.50 to 15.00% (v/w), 1.00 to 15.00% (v/w), based on the total enzyme reaction. ), 2.50 to 15.00% (v/w), 5.00 to 15.00% (v/w), 0.10 to 10.00% (v/w), 0.50 to 10.00% (v/w), 1.00 to 10.00% (v/w) ), 2.50 to 10.00% (v/w), 5.00 to 10.00% (v/w), 0.10 to 7.50% (v/w), 0.50 to 7.50% (v/w), 1.00 to 7.50% (v/w) ), 2.50 to 7.50% (v/w), 5.00 to 7.50% (v/w), 0.10 to 5.00% (v/w), 0.50 to 5.00% (v/w), or 1.00 to 5.00% (v/ w), for example, 2.50 to 5.00% (v/w), but is not limited thereto.
본 발명에 있어서 상기 반응 단계는 1 내지 24시간 동안 수행되는 것일 수 있다.In the present invention, the reaction step may be performed for 1 to 24 hours.
상기 반응 용액이 아스퍼질러스 나이거 균주의 배양 상등액의 분획물인 경우, 바람직하게는 상기 반응 단계는 2 내지 24시간, 3 내지 24시간, 4 내지 24시간, 6 내지 24시간, 또는 10 내지 24시간 동안 수행되는 것일 수 있고, 예를 들어, 12 내지 24시간 동안 수행되는 것일 수 있으나, 이에 한정되는 것은 아니다.When the reaction solution is a fraction of the culture supernatant of the Aspergillus niger strain, preferably the reaction step lasts 2 to 24 hours, 3 to 24 hours, 4 to 24 hours, 6 to 24 hours, or 10 to 24 hours. It may be performed for a period of time, for example, 12 to 24 hours, but is not limited thereto.
상기 반응 용액이 아스퍼질러스 오리재 균주의 배양 상등액인 경우, 바람직하게는 상기 반응 단계는 2 내지 24시간, 4 내지 24시간, 6 내지 24시간, 8 내지 24시간, 10 내지 24시간, 또는 12 내지 24시간 동안 수행되는 것일 수 있고, 예를 들어, 15 내지 24시간 동안 수행되는 것일 수 있으나, 이에 한정되는 것은 아니다.When the reaction solution is a culture supernatant of an Aspergillus oryzae strain, preferably the reaction step is 2 to 24 hours, 4 to 24 hours, 6 to 24 hours, 8 to 24 hours, 10 to 24 hours, or 12 hours. It may be performed for from 15 to 24 hours, for example, 15 to 24 hours, but is not limited thereto.
본 발명의 다른 양태는 유자를 포함하는 기질조성물에 아스퍼질러스 나이거 또는 아스퍼질러스 오리재 균주, 상기 균주의 배양물, 상기 배양물의 농축물, 상기 배양물의 건조물, 상기 균주의 배양 상등액 및 상기 배양 상등액의 분획물로 이루어진 군으로부터 선택된 1종 이상을 포함하는 반응 용액을 반응시켜 제조된, 쓴맛이 저감된 유자 효소반응물을 포함하는 다이어트용 건강기능식품 조성물이다.Another aspect of the present invention is a substrate composition containing citron, an Aspergillus niger or Aspergillus duckweed strain, a culture of the strain, a concentrate of the culture, a dried product of the culture, a culture supernatant of the strain, and the above. It is a health functional food composition for diet containing a citron enzyme reaction product with reduced bitter taste, prepared by reacting a reaction solution containing one or more selected from the group consisting of fractions of culture supernatants.
본 발명에 있어서 상기 유자는 당절임, 동결건조분말, 농축액 및 착즙액으로 이루어진 군으로부터 선택되는 1종 이상의 형태로 제공되는 것일 수 있다.In the present invention, the citron may be provided in one or more forms selected from the group consisting of pickled sugar, freeze-dried powder, concentrate, and juice.
본 발명에 있어서 상기 유자는 과실 전체, 과육 및 과피로 이루어진 군으로부터 선택되는 1종 이상인 것일 수 있다.In the present invention, the citron may be one or more types selected from the group consisting of the whole fruit, pulp, and skin.
본 발명에 있어서 상기 아스퍼질러스 나이거 균주의 배양 상등액은 β-글루코시데이즈, 셀룰레이즈, 헤미셀룰레이즈 및 프로테이즈로 이루어진 군으로부터 선택되는 1종 이상을 포함하는 것일 수 있고, 예를 들어, β-글루코시데이즈, 셀룰레이즈, 헤미셀룰레이즈 및 프로테이즈를 모두 포함하는 것일 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the culture supernatant of the Aspergillus niger strain may contain one or more types selected from the group consisting of β-glucosidase, cellulase, hemicellulase, and protease, for example , may include all of β-glucosidase, cellulase, hemicellulase, and protease, but are not limited thereto.
본 발명에 있어서 상기 아스퍼질러스 오리재 균주는 수탁번호 KCTC14898BP로 기탁된 아스퍼질러스 오리재 NYO2 균주인 것일 수 있다.In the present invention, the Aspergillus duck material strain may be the Aspergillus duck material NYO2 strain deposited under the accession number KCTC14898BP.
본 발명에 있어서 상기 반응 용액의 농도는 전체 효소반응물에 대하여 0.01 내지 1.00%(v/v)인 것일 수 있다.In the present invention, the concentration of the reaction solution may be 0.01 to 1.00% (v/v) based on the total enzyme reaction product.
상기 반응 용액이 아스퍼질러스 나이거 균주의 배양 상등액의 분획물인 경우, 상기 배양 상등액의 분획물은 β-글루코시데이즈, 셀룰레이즈, 헤미셀룰레이즈 및 프로테이즈를 포함하는 것일 수 있고, 바람직하게는 상기 반응 용액의 농도는 전체 효소반응물에 대하여 0.02 내지 1.00%(v/v), 0.05 내지 1.00%(v/v), 0.08 내지 1.00%(v/v), 0.10 내지 1.00%(v/v), 0.01 내지 0.50%(v/v), 0.02 내지 0.50%(v/v), 0.05 내지 0.50%(v/v), 0.08 내지 0.50%(v/v), 0.10 내지 0.50%(v/v), 0.01 내지 0.20%(v/v), 0.02 내지 0.20%(v/v), 0.05 내지 0.20%(v/v), 0.08 내지 0.20%(v/v), 0.10 내지 0.20%(v/v), 0.01 내지 0.10%(v/v), 0.02 내지 0.10%(v/v), 또는 0.05 내지 0.10%(v/v)인 것일 수 있고, 예를 들어, 0.08 내지 0.20%(v/v)인 것일 수 있으나, 이에 한정되는 것은 아니다.When the reaction solution is a fraction of the culture supernatant of the Aspergillus niger strain, the fraction of the culture supernatant may include β-glucosidase, cellulase, hemicellulase, and protease, preferably The concentration of the reaction solution is 0.02 to 1.00% (v/v), 0.05 to 1.00% (v/v), 0.08 to 1.00% (v/v), 0.10 to 1.00% (v/v) based on the total enzyme reaction product. , 0.01 to 0.50% (v/v), 0.02 to 0.50% (v/v), 0.05 to 0.50% (v/v), 0.08 to 0.50% (v/v), 0.10 to 0.50% (v/v) , 0.01 to 0.20% (v/v), 0.02 to 0.20% (v/v), 0.05 to 0.20% (v/v), 0.08 to 0.20% (v/v), 0.10 to 0.20% (v/v) , may be 0.01 to 0.10% (v/v), 0.02 to 0.10% (v/v), or 0.05 to 0.10% (v/v), for example, 0.08 to 0.20% (v/v). It may be, but is not limited to this.
상기 반응 용액이 아스퍼질러스 오리재 균주의 배양 상등액인 경우, 바람직하게는 상기 반응 용액의 농도는 전체 효소반응물에 대하여 0.02 내지 1.00%(v/v), 0.05 내지 1.00%(v/v), 0.08 내지 1.00%(v/v), 0.10 내지 1.00%(v/v), 0.20 내지 1.00%(v/v), 0.50 내지 1.00%(v/v), 0.01 내지 0.80%(v/v), 0.02 내지 0.80%(v/v), 0.05 내지 0.80%(v/v), 0.08 내지 0.80%(v/v), 0.10 내지 0.80%(v/v), 0.20 내지 0.80%(v/v), 0.50 내지 0.80%(v/v), 0.01 내지 0.50%(v/v), 0.02 내지 0.50%(v/v), 0.05 내지 0.50%(v/v), 0.08 내지 0.50%(v/v), 또는 0.10 내지 0.50%(v/v)인 것일 수 있고, 예를 들어, 0.20 내지 0.50%(v/v)인 것일 수 있으나, 이에 한정되는 것은 아니다.When the reaction solution is a culture supernatant of Aspergillus oryzae strain, the concentration of the reaction solution is preferably 0.02 to 1.00% (v/v), 0.05 to 1.00% (v/v), based on the total enzyme reaction product. 0.08 to 1.00% (v/v), 0.10 to 1.00% (v/v), 0.20 to 1.00% (v/v), 0.50 to 1.00% (v/v), 0.01 to 0.80% (v/v), 0.02 to 0.80% (v/v), 0.05 to 0.80% (v/v), 0.08 to 0.80% (v/v), 0.10 to 0.80% (v/v), 0.20 to 0.80% (v/v), 0.50 to 0.80% (v/v), 0.01 to 0.50% (v/v), 0.02 to 0.50% (v/v), 0.05 to 0.50% (v/v), 0.08 to 0.50% (v/v), Alternatively, it may be 0.10 to 0.50% (v/v), for example, 0.20 to 0.50% (v/v), but is not limited thereto.
본 발명에 있어서 상기 기질조성물의 농도는 전체 효소반응물에 대하여 0.10 내지 15.00%(v/w)인 것일 수 있고, 바람직하게는 0.50 내지 15.00%(v/w), 1.00 내지 15.00%(v/w), 2.50 내지 15.00%(v/w), 5.00 내지 15.00%(v/w), 0.10 내지 10.00%(v/w), 0.50 내지 10.00%(v/w), 1.00 내지 10.00%(v/w), 2.50 내지 10.00%(v/w), 5.00 내지 10.00%(v/w), 0.10 내지 7.50%(v/w), 0.50 내지 7.50%(v/w), 1.00 내지 7.50%(v/w), 2.50 내지 7.50%(v/w), 5.00 내지 7.50%(v/w), 0.10 내지 5.00%(v/w), 0.50 내지 5.00%(v/w), 또는 1.00 내지 5.00%(v/w)인 것일 수 있고, 예를 들어, 2.50 내지 5.00%(v/w)인 것일 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the concentration of the substrate composition may be 0.10 to 15.00% (v/w), preferably 0.50 to 15.00% (v/w), 1.00 to 15.00% (v/w), based on the total enzyme reaction. ), 2.50 to 15.00% (v/w), 5.00 to 15.00% (v/w), 0.10 to 10.00% (v/w), 0.50 to 10.00% (v/w), 1.00 to 10.00% (v/w) ), 2.50 to 10.00% (v/w), 5.00 to 10.00% (v/w), 0.10 to 7.50% (v/w), 0.50 to 7.50% (v/w), 1.00 to 7.50% (v/w) ), 2.50 to 7.50% (v/w), 5.00 to 7.50% (v/w), 0.10 to 5.00% (v/w), 0.50 to 5.00% (v/w), or 1.00 to 5.00% (v/ w), for example, 2.50 to 5.00% (v/w), but is not limited thereto.
본 발명에 있어서 상기 유자 효소반응물은 상기 반응 용액과 반응시킴에 따라 기질조성물 대비 용해도, 수분보유력(Water holding capacity; WHC), 유지보유력(Oil holding capacity; OHC) 및 팽윤력(Swelling capacity; SC)으로 이루어진 군으로부터 선택되는 1종 이상의 특성이 증진된 것일 수 있다. 이와 같은 특성의 증진에 따라, 본 발명의 유자 효소반응물은 물에 잘 수화되고, 생체 이용률이 크게 향상되어 다이어트용 식품 조성물로서 효과적으로 이용될 수 있다.In the present invention, the citron enzyme reaction product reacts with the reaction solution to improve solubility, water holding capacity (WHC), oil holding capacity (OHC), and swelling capacity (SC) compared to the substrate composition. One or more characteristics selected from the group consisting of may be improved. With the improvement of these properties, the yuzu enzyme reaction product of the present invention is well hydrated in water and its bioavailability is greatly improved, so that it can be effectively used as a food composition for diet.
본 발명의 건강기능식품 조성물을 식품 첨가물로 사용할 경우, 상기 건강기능식품 조성물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용할 수 있고, 통상적인 방법에 따라 적절하게 사용할 수 있다. 일반적으로, 식품 또는 음료의 제조 시에 본 발명의 건강기능식품 조성물은 원료에 대하여 15 중량% 이하, 바람직하게는 10 중량% 이하의 양으로 첨가될 수 있다.When using the health functional food composition of the present invention as a food additive, the health functional food composition can be added as is or used together with other foods or food ingredients, and can be used appropriately according to conventional methods. In general, when manufacturing a food or beverage, the health functional food composition of the present invention may be added in an amount of 15% by weight or less, preferably 10% by weight or less, based on the raw materials.
상기 식품의 종류에는 특별한 제한은 없다. 상기 물질을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 초콜릿, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 식품을 모두 포함한다.There are no special restrictions on the types of foods above. Examples of foods to which the above substances can be added include meat, sausages, bread, chocolate, candies, snacks, confectionery, pizza, ramen, other noodles, gum, dairy products including ice cream, various soups, beverages, tea, drinks, etc. These include alcoholic beverages and vitamin complexes, and include all foods in the conventional sense.
상기 음료는 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 당업자의 선택에 의해 적절하게 결정될 수 있다.The beverage may contain various flavors or natural carbohydrates as additional ingredients. The above-mentioned natural carbohydrates may include monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, natural sweeteners such as dextrin and cyclodextrin, and synthetic sweeteners such as saccharin and aspartame. . The ratio of the natural carbohydrates can be appropriately determined by the selection of a person skilled in the art.
상기 외에 본 발명의 건강기능식품 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 건강기능식품 조성물은 천연 과일쥬스, 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율 또한 당업자에 의해 적절히 선택될 수 있다.In addition to the above, the health functional food composition of the present invention includes various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, and glycerin. , alcohol, and carbonating agents used in carbonated beverages. In addition, the health functional food composition of the present invention may contain pulp for the production of natural fruit juice, fruit juice drinks, and vegetable drinks. These ingredients can be used independently or in combination. The proportions of these additives can also be appropriately selected by those skilled in the art.
본 발명은 쓴맛이 저감된 유자 효소반응물의 제조 방법 및 이를 포함하는 다이어트용 건강기능식품 조성물에 관한 것으로서, 상기 유자 효소반응물은 유자 고유의 쓴맛이 효과적으로 감소하였을 뿐만 아니라 입자의 크기가 줄어 용해도가 향상되고 균일도와 분산도 또한 상승하였으며, 이로부터 분리된 식이섬유는 지방 생성 억제 또는 지방 분해 촉진에 유용할 것으로 예상되므로, 이를 효과적으로 다이어트용 건강기능식품 조성물의 제조에 이용할 수 있다.The present invention relates to a method for producing a citron enzyme reaction with reduced bitterness and a health functional food composition for diet containing the same. The citron enzyme reaction product not only effectively reduces the inherent bitterness of citron, but also improves solubility by reducing particle size. The uniformity and dispersion also increased, and the dietary fiber isolated from this is expected to be useful in suppressing fat production or promoting lipolysis, so it can be effectively used in the production of a health functional food composition for diet.
도 1은 본 발명의 일 실시예에 따라 동정된 수탁번호 KCTC 14898BP로 기탁된 아스퍼질러스 오리재(Aspergillus oryzae) NYO-2 균주의 계통수를 보여주는 모식도이다.
도 2a는 본 발명의 일 실시예에 따라 유자 시료에 상업용 효소를 반응시켜 쓴맛 성분의 변화를 나타낸 TLC(Thin Layer Chromatography) 분석 결과 사진이다.
도 2b는 본 발명의 일 실시예에 따라 유자 시료에 대한 균주 배양 상등액 처리군에서 쓴맛 성분의 변화를 나타낸 TLC 분석 결과 사진이다.
도 3은 본 발명의 일 실시예에 따라 유자 시료에 대한 상업용 효소 및 균주 배양 상등액 처리군에서 나린진 및 네오헤스페리딘의 제거율을 나타낸 그래프이다.
도 4는 본 발명의 일 실시예에 따라 유자 기질별 시료에 대한 KN 효소 및 아스퍼질러스 오리재 NYO2 균주의 배양 상등액 처리군에서 나린진 및 네오헤스페리딘의 제거율을 나타낸 그래프이다.
도 5a는 본 발명의 일 실시예에 따라 유자 시료에 대한 농도별 KN 효소 처리군에서 나린진 및 네오헤스페리딘의 제거율을 나타낸 사진이다.
도 5b는 본 발명의 일 실시예에 따라 유자 기질 시료 농도를 달리한 KN 효소 처리군에서 나린진 및 네오헤스페리딘의 제거율을 나타낸 사진이다.
도 5c는 본 발명의 일 실시예에 따라 유자 시료에 대한 KN 효소 처리군에서 반응 시간에 따른 나린진 및 네오헤스페리딘의 제거율을 나타낸 사진이다.
도 6a는 본 발명의 일 실시예에 따라 유자 시료에 대한 농도별 효소 처리군에서 나린진 및 네오헤스페리딘의 제거율을 나타낸 그래프이다.
도 6b는 본 발명의 일 실시예에 따라 유자 기질 시료 농도를 달리한 KN 효소 처리군에서 나린진 및 네오헤스페리딘의 제거율을 나타낸 그래프이다.
도 6c는 본 발명의 일 실시예에 따라 유자 시료에 대한 KN 효소 처리군에서 반응 시간에 따른 나린진 및 네오헤스페리딘의 제거율을 나타낸 그래프이다.
도 7a는 본 발명의 일 실시예에 따라 유자 시료에 대한 농도별 아스퍼질러스 오리재 NYO2 균주 배양 상등액 처리군에서 농도별 나린진 및 네오헤스페리딘의 제거율을 나타낸 사진이다.
도 7b는 본 발명의 일 실시예에 따라 유자 기질 시료 농도를 달리한 아스퍼질러스 오리재 NYO2 균주 배양 상등액 처리군에서 나린진 및 네오헤스페리딘의 제거율을 나타낸 사진이다.
도 7c는 본 발명의 일 실시예에 따라 유자 시료에 대한 아스퍼질러스 오리재 NYO2 균주 배양 상등액 처리군에서 반응 시간에 따른 나린진 및 네오헤스페리딘의 제거율을 나타낸 사진이다.
도 8a는 본 발명의 일 실시예에 따라 유자 시료에 대한 농도별 아스퍼질러스 오리재 NYO2 균주 배양 상등액 처리군에서 농도별 나린진 및 네오헤스페리딘의 제거율을 나타낸 그래프이다.
도 8b는 본 발명의 일 실시예에 따라 유자 기질 시료 농도를 달리하고 아스퍼질러스 오리재 NYO2 균주 배양 상등액 처리군에서 나린진 및 네오헤스페리딘의 제거율을 나타낸 그래프이다.
도 8c는 본 발명의 일 실시예에 따라 유자 시료에 대한 아스퍼질러스 오리재 NYO2 균주 배양 상등액 처리군에서 반응 시간에 따른 나린진 및 네오헤스페리딘의 제거율을 나타낸 그래프이다.
도 9a는 본 발명의 일 실시예에 따른 청유자 시료에 대한 KN 효소 처리와 NYO2 균주 배양 상등액 처리군의 시료 사진이다.
도 9b는 본 발명의 일 실시예에 따른 황유자 시료에 대한 KN 효소 처리와 NYO2 균주 배양 상등액 처리군의 시료 사진이다.
도 10a는 본 발명의 일 실시예에 따른 청유자 시료에 대한 KN 효소 처리와 NYO2 균주 배양 상등액 처리군의 맛 변화를 확인한 전자혀 분석 그래프이다.
도 10b는 본 발명의 일 실시예에 따른 황유자 시료에 대한 KN 효소 처리와 NYO2 균주 배양 상등액 처리군의 맛 변화를 확인한 전자혀 분석 그래프이다.
도 11은 본 발명의 일 실시예에 따른 청유자 및 황유자 시료에 대한 KN 효소 처리와 NYO2 균주 배양 상등액 처리군의 쓴맛 감소 정도를 확인한 전자혀 분석 그래프이다.
도 12a는 본 발명의 일 실시예에 따른 청유자 시료에 대한 KN 효소 처리와 NYO2 균주 배양 상등액 처리군의 분말 크기 및 분산도를 확인한 그래프이다.
도 12b는 본 발명의 일 실시예에 따른 황유자 시료에 대한 KN 효소 처리와 NYO2 균주 배양 상등액 처리군의 분말 크기 및 분산도를 확인한 그래프이다.
도 13은 본 발명의 일 실시예에 따른 유자 시료에 대한 KN 효소 처리와 NYO2 균주 배양 상등액 처리군의 구조 변화를 확인한 FTIR 분석 결과 그래프이다.
도 14는 본 발명의 일 실시예에 따른 유자 시료의 표면을 촬영한 주사전자현미경(Scanning Electron Microscope; SEM) 사진이다.
도 15는 본 발명의 일 실시예에 따른 유자 시료의 지방세포 분화 억제 효과를 확인한 사진이다.
도 16a는 본 발명의 일 실시예에 따른 청유자 시료의 지방 세포 분화 억제 효과를 확인한 그래프이다.
도 16b는 본 발명의 일 실시예에 따른 황유자 시료의 지방 세포 분화 억제 효과를 확인한 그래프이다.
도 17a는 본 발명의 일 실시예에 따른 청유자 시료의 지방 분해 촉진 효과를 확인한 그래프이다.
도 17b는 본 발명의 일 실시예에 따른 황유자 시료의 지방 분해 촉진 효과를 확인한 그래프이다.
도 18은 본 발명의 일 실시예에 따른 유자 시료의 지방산 합성 효소 함량을 나타낸 그래프이다.Figure 1 is a schematic diagram showing the phylogenetic tree of the Aspergillus oryzae NYO-2 strain deposited with the accession number KCTC 14898BP, identified according to an embodiment of the present invention.
Figure 2a is a photograph of the results of TLC (Thin Layer Chromatography) analysis showing changes in bitter taste components by reacting a commercial enzyme with a citron sample according to an embodiment of the present invention.
Figure 2b is a photo of the TLC analysis results showing changes in bitter taste components in the group treated with the strain culture supernatant of the citron sample according to an embodiment of the present invention.
Figure 3 is a graph showing the removal rates of naringin and neohesperidin in the group treated with commercial enzyme and strain culture supernatant for citron samples according to an embodiment of the present invention.
Figure 4 is a graph showing the removal rate of naringin and neohesperidin in a group treated with KN enzyme and culture supernatant of Aspergillus duckweed NYO2 strain for samples of each citron substrate according to an embodiment of the present invention.
Figure 5a is a photograph showing the removal rates of naringin and neohesperidin in the KN enzyme treatment group at each concentration of citron samples according to an embodiment of the present invention.
Figure 5b is a photograph showing the removal rates of naringin and neohesperidin in the KN enzyme treatment group with different concentration of citron substrate samples according to an embodiment of the present invention.
Figure 5c is a photograph showing the removal rates of naringin and neohesperidin according to reaction time in the KN enzyme treatment group for citron samples according to an embodiment of the present invention.
Figure 6a is a graph showing the removal rates of naringin and neohesperidin in enzyme treatment groups at different concentrations for citron samples according to an embodiment of the present invention.
Figure 6b is a graph showing the removal rates of naringin and neohesperidin in the KN enzyme treatment group with different citron substrate sample concentrations according to an embodiment of the present invention.
Figure 6c is a graph showing the removal rates of naringin and neohesperidin according to reaction time in the KN enzyme treatment group for citron samples according to an embodiment of the present invention.
Figure 7a is a photograph showing the removal rates of naringin and neohesperidin by concentration in groups treated with Aspergillus oryzae NYO2 strain culture supernatant at different concentrations for citron samples according to an embodiment of the present invention.
Figure 7b is a photograph showing the removal rate of naringin and neohesperidin in a group treated with the culture supernatant of Aspergillus duckweed NYO2 strain with different concentration of citron substrate samples according to an embodiment of the present invention.
Figure 7c is a photograph showing the removal rate of naringin and neohesperidin according to reaction time in the group treated with the Aspergillus oryzae NYO2 strain culture supernatant for the citron sample according to an embodiment of the present invention.
Figure 8a is a graph showing the removal rate of naringin and neohesperidin by concentration in the Aspergillus oryzae NYO2 strain culture supernatant treatment group at each concentration for the citron sample according to an embodiment of the present invention.
Figure 8b is a graph showing the removal rates of naringin and neohesperidin in groups treated with culture supernatant of Aspergillus duckweed NYO2 strain with different concentration of citron substrate samples according to an embodiment of the present invention.
Figure 8c is a graph showing the removal rate of naringin and neohesperidin according to reaction time in the Aspergillus duck material NYO2 strain culture supernatant treatment group for the citron sample according to an embodiment of the present invention.
Figure 9a is a photograph of a sample of a KN enzyme treatment and NYO2 strain culture supernatant treatment group for a green citron sample according to an embodiment of the present invention.
Figure 9b is a photograph of a sample of a group treated with KN enzyme treatment and NYO2 strain culture supernatant for a yellow citron sample according to an embodiment of the present invention.
Figure 10a is an electronic tongue analysis graph confirming the taste change of the KN enzyme treatment and NYO2 strain culture supernatant treatment group for the green citron sample according to an embodiment of the present invention.
Figure 10b is an electronic tongue analysis graph confirming the taste change of the KN enzyme treatment and NYO2 strain culture supernatant treatment group for the yellow citron sample according to an embodiment of the present invention.
Figure 11 is an electronic tongue analysis graph confirming the degree of bitterness reduction in the KN enzyme treatment and NYO2 strain culture supernatant treatment group for green citron and yellow citron samples according to an embodiment of the present invention.
Figure 12a is a graph confirming the powder size and dispersion of the KN enzyme treatment and NYO2 strain culture supernatant treatment group for the green citron sample according to an embodiment of the present invention.
Figure 12b is a graph confirming the powder size and dispersion of the KN enzyme treatment and NYO2 strain culture supernatant treatment group for the yellow citron sample according to an embodiment of the present invention.
Figure 13 is a graph showing the results of FTIR analysis confirming the structural changes in the KN enzyme treatment and NYO2 strain culture supernatant treatment groups for citron samples according to an embodiment of the present invention.
Figure 14 is a scanning electron microscope (SEM) photograph of the surface of a citron sample according to an embodiment of the present invention.
Figure 15 is a photograph confirming the inhibitory effect of adipocyte differentiation of a citron sample according to an embodiment of the present invention.
Figure 16a is a graph confirming the effect of suppressing adipocyte differentiation of a green citron sample according to an embodiment of the present invention.
Figure 16b is a graph confirming the effect of suppressing adipocyte differentiation of a yellow citron sample according to an embodiment of the present invention.
Figure 17a is a graph confirming the effect of promoting lipolysis of a green citron sample according to an embodiment of the present invention.
Figure 17b is a graph confirming the effect of promoting lipolysis of a yellow citron sample according to an embodiment of the present invention.
Figure 18 is a graph showing the fatty acid synthase content of a citron sample according to an embodiment of the present invention.
이하, 본 발명을 하기의 실시예에 의하여 더욱 상세히 설명한다. 그러나 이들 실시예는 본 발명을 예시하기 위한 것일 뿐이며, 본 발명의 범위가 이들 실시예에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through the following examples. However, these examples are only for illustrating the present invention, and the scope of the present invention is not limited by these examples.
본 명세서 전체에 걸쳐, 특정 물질의 농도를 나타내기 위하여 사용되는 "%"는 별도의 언급이 없는 경우, 고체/고체는 (중량/중량)%, 고체/액체는 (중량/부피)%, 그리고 액체/액체는 (부피/부피)%이다.Throughout this specification, “%” used to indicate the concentration of a specific substance means (weight/volume)% for solid/solid, (weight/volume)% for solid/liquid, and Liquid/liquid is (volume/volume)%.
모든 실험결과는 3회 반복 측정한 값을 평균값과 표준편차로 나타내었다. 결과분석은 SPSS 프로그램(v27.0, IBM Company, Chicago, IL, USA)을 사용하여 분산분석(ANOVA)하였으며, 시료간의 유의성 차이를 검정하기위해 Duncan's multiple range test를 p<0.05 수준에서 실시하였다.All experimental results were measured three times and were expressed as the average value and standard deviation. The results were analyzed using SPSS program (v27.0, IBM Company, Chicago, IL, USA), and Duncan's multiple range test was performed at the p<0.05 level to test the significance difference between samples.
실시예 1: 유자 분말로부터 쓴맛 성분을 제거하기 위한 효소 조건화Example 1: Enzyme conditioning to remove bitter taste components from citron powder
1-1. 효소의 선발1-1. Selection of enzymes
본 연구에서는 전라남도 농업기술원 과수 연구 시험장 완도 시험지로부터 남해품종 청유자를 얻었으며, 청유자를 동결건조 후 분말형태로 만들어서 -80℃에 저장하여 실험에 사용하였다. 분말은 60 메쉬(mesh) 체를 이용해 균일화하였다.In this study, the South Sea variety of green citron was obtained from the Wando test site of the Orchard Research and Experiment Center of the Jeollanam-do Agricultural Research and Extension Services, and the green citron was freeze-dried, made into powder, stored at -80°C, and used in the experiment. The powder was homogenized using a 60 mesh sieve.
청유자의 쓴맛을 제거하기 위해 청유자 분말을 보유중인 상업용 효소와 반응하였다. TLC와 HPLC 분석을 수행함에 있어서 효소처리 하지 않은 무처리군으로는 유자분말을 5% 농도로 물에 용해시킨 뒤의 상등액을 적용하여 분석하였다. 표준물질로는 나린진(Ng), 프루닌(P), 나린제닌(Nn), 네오헤스페리딘(Neo), 헤스페리틴(Ht), 헤스페리딘(Hd), 람노스(Rha), 프럭토스(Fru), 글루코스(Glc), 수크로스(Suc), 덱스트린(Sigma-Aldrich, St.Louis, MO, USA)을 이용하였으며, 효소를 넣지 않은 반응액(enzyme blank; EB)에 비해 나린진이 감소되는 경우 처리한 효소가 나린진 분해능이 우수한 것으로 판단할 수 있다.To remove the bitter taste of green citron, green citron powder was reacted with a commercially available enzyme. When performing TLC and HPLC analysis, the supernatant obtained by dissolving citron powder in water at a concentration of 5% was applied to the untreated group without enzyme treatment. Standard substances include naringin (Ng), prunin (P), naringenin (Nn), neohesperidin (Neo), hesperitin (Ht), hesperidin (Hd), rhamnose (Rha), fructose (Fru), Glucose (Glc), sucrose (Suc), and dextrin (Sigma-Aldrich, St.Louis, MO, USA) were used, and when naringin was reduced compared to the reaction solution without enzyme (enzyme blank; EB), the treated It can be judged that the enzyme has excellent naringin decomposition ability.
상업용 효소의 경우 XXL, RP, RF, CP, UF, PR, SP-L, KN(Celluase KN, B-glucosidase 20 U/g 비젼바이오캠), 100L을 사용하였다.For commercial enzymes, XXL, RP, RF, CP, UF, PR, SP-L, KN (Celluase KN, B-glucosidase 20 U/g Vision Biocam), 100L were used.
헤미셀룰레이즈(Hemicellulase)Polygalacturonase, cellulase
Hemicellulase
균주 유래 효소의 경우 나린진 분해능이 우수한 것으로 판명된 수탁번호 KCTC 14898BP로 기탁된 아스퍼질러스 오리재(Aspergillus oryzae) NYO-2 균주 유래의 효소를 유자분말에 처리하였고, 대조구로 공시균주 A. oryzae KTCC 6377 균주 유래의 효소를 사용하였다.In the case of strain-derived enzymes, enzymes derived from the Aspergillus oryzae NYO-2 strain deposited under the accession number KCTC 14898BP, which were found to have excellent naringin decomposition ability, were treated with citron powder, and the test strain A. oryzae KTCC was used as a control. Enzyme derived from strain 6377 was used.
아스퍼질러스 오리재 NYO-2 균주는 유자를 사용한 16종의 전통식품으로부터 수집한 시료를 현탁 후 영양 배지에서 정치 배양하고, 이로부터 피킹된 690개의 콜로니들을 분리 배양하여 단일 콜로니들을 취하고, 이들 중 나린진 분해능이 뛰어난 69종의 균주를 선발하고, 이 중 당분해 효능이 높은 6종의 균주를 선발한 후 나린진 분해능이 가장 우수한 특성을 확인함으로써 선발된 균주이다. 계통 발생수는 MEGA 2.1.0 패키지를 이용한 maximum-likelihood에 따라 도 1과 같이 분석하였고, 하기 표 2와 같이 18S rRNA 서열을 나타내었다.For the Aspergillus duckweed NYO-2 strain, samples collected from 16 types of traditional foods using yuzu were suspended and cultured on a nutrient medium, and 690 colonies picked from them were isolated and cultured to select single colonies. This strain was selected by selecting 69 strains with excellent naringin decomposition ability, selecting 6 strains with high glycolysis efficiency, and then confirming the characteristics of the best naringin decomposition ability. The phylogenetic tree was analyzed as shown in Figure 1 according to maximum-likelihood using the MEGA 2.1.0 package, and the 18S rRNA sequence is shown in Table 2 below.
균주 유래의 효소를 얻기 위해 각 균주는 MDN 배지(Davis minimal broth, Dipotassium phosphate 0.7%, Monopotassium phosphate 0.2%, Sodium citrate 0.05%, Magnesium sulfate 0.01% Ammonium sulfate 0.1%) 10 mL에 접종하고, 37℃에서 120 rpm으로 교반하며 7일간 배양하였다. 배양된 균주는 8,000 rpm에서 10분간 원심분리(6200, Kubota, Tokyo, Japan) 하여 상등액을 효소액으로 사용하였다.To obtain strain-derived enzymes, each strain was inoculated into 10 mL of MDN medium (Davis minimal broth, Dipotassium phosphate 0.7%, Monopotassium phosphate 0.2%, Sodium citrate 0.05%, Magnesium sulfate 0.01% and Ammonium sulfate 0.1%) and incubated at 37°C. The culture was cultured for 7 days while stirring at 120 rpm. The cultured strain was centrifuged at 8,000 rpm for 10 minutes (6200, Kubota, Tokyo, Japan), and the supernatant was used as an enzyme solution.
1-2. 효소반응의 수행1-2. Carrying out enzyme reactions
효소반응은 청유자 분말 50 mg을 20 mM 소듐-아세테이트(sodium-acetate) 완충용액 0.9 mL로 용해시킨 뒤 효소를 최종농도 0.1%로 첨가시켜 반응하였다. 37℃에서 12시간 동안 반응하였으며, 반응이 완료된 청유자 분말은 100℃에서 15분간 효소를 실활시킨 뒤 상등액에 대하여 TLC(Thin Layer Chromatography) 및 HPLC(high-performance liquid chromatography) 분석을 수행하였다.For the enzyme reaction, 50 mg of green citron powder was dissolved in 0.9 mL of 20 mM sodium-acetate buffer solution, and then enzyme was added to a final concentration of 0.1%. The reaction was conducted at 37°C for 12 hours, and upon completion of the reaction, the enzyme was deactivated at 100°C for 15 minutes, and the supernatant was subjected to TLC (Thin Layer Chromatography) and HPLC (high-performance liquid chromatography) analysis.
TLC 분석(1차 스크리닝)을 위하여 효소반응액 1 μL를 실리카겔 TLC plate에 점적하고, 전개용매는 에틸아세테이트(ethylacetate):아세트산(acetic acid):DW (3:1:1, v/v/v)를 사용하여 45분간 1회 전개하였으며, UV 245 nm와 발색용매 (황산 5 mL, 95 mL 메탄올, N-(1-naphthyl) ethylenediamine 0.05 g을 혼합한 용액)에 TLC plate를 담근 뒤 120℃에서 5분간 굽고 스폿(spot)을 확인하였다.For TLC analysis (primary screening), 1 μL of the enzyme reaction solution was spotted on a silica gel TLC plate, and the developing solvent was ethyl acetate:acetic acid:DW (3:1:1, v/v/v) ) was developed once for 45 minutes, and the TLC plate was immersed in UV 245 nm and a coloring solvent (a solution of 5 mL of sulfuric acid, 95 mL of methanol, and 0.05 g of N-(1-naphthyl) ethylenediamine) and then incubated at 120°C. Bake for 5 minutes and check the spot.
표 3, 도 2a 및 2b에서 확인할 수 있듯이, TLC 상에서 무처리군과 비교시 XXL, RP, RF, CP, UF, PR, SP-L, KN, 100L은 나린진과 네오헤스페리딘을 9.2%, 78.9%, 84.6%, 20.3%, 16.3%, 12.7%, 1.3%, 88.8%, 85.2%를 제거하여 이중 KN이 나린진과 네오헤스페리딘을 모두 88% 이상 감소시켜 쓴맛 감소에 가장 우수한 모습을 보였다.As can be seen in Table 3 and Figures 2a and 2b, when compared to the untreated group on TLC, XXL, RP, RF, CP, UF, PR, SP-L, KN, 100L contained naringin and neohesperidin by 9.2% and 78.9%, respectively. Among them, KN showed the best performance in reducing bitterness by reducing both naringin and neohesperidin by more than 88%.
HPLC 분석을 위하여 나린진, 네오헤스페리딘으로 시료의 플라보노이드 함량을 측정하였으며 1216 Infinity LC(Agilent Technologies, Inc., Santa Clara, CA, USA)를 사용하였다. 컬럼(Column)으로는 C18(Eclipse plus C18, 4.6 X 250 nm, Zorbax)을 사용하여 280 nm에서 확인하였고, 시료 주입량은 10 μL, 컬럼 오븐(column oven)은 35℃를 유지하였다. 이동상용매로는 아세토니트릴(acetonitrile)(A), 증류수에 포름산(formic acid)을 0.1% 혼합한 물(water)(B)을 사용하였으며, 유속을 1 mL/min을 유지한 상태에서 시작할 때 A: 20, B: 80; 5-10분일 때 A: 40, B: 60; 10-15분일 때 A: 50, B: 50; 15-20분일 때 A: 70, B: 30; 20-25분일때 A: 100, B: 0으로 25분간 분석하였다. 표준품으로 사용된 나린진, 네오헤스페리딘은 Sigma-Aldrich에서 구입하여 사용하였다.For HPLC analysis, the flavonoid content of the sample was measured with naringin and neohesperidin, and 1216 Infinity LC (Agilent Technologies, Inc., Santa Clara, CA, USA) was used. It was confirmed at 280 nm using C18 (Eclipse plus C18, 4.6 Acetonitrile (A) and 0.1% formic acid mixed with distilled water (B) were used as mobile phase solvents. When starting with the flow rate maintained at 1 mL/min, A : 20, B: 80; At 5-10 minutes, A: 40, B: 60; For 10-15 minutes, A: 50, B: 50; When 15-20 minutes, A: 70, B: 30; At 20-25 minutes, A: 100, B: 0 were analyzed for 25 minutes. Naringin and neohesperidin used as standards were purchased from Sigma-Aldrich.
또한 도 3에서 확인할 수 있듯이, 아스퍼질러스 오리재 NYO-2 균주 유래의 나린지네이즈(naringinase)는 KTCC 6377(공시균주)에서 보여준 40%의 제거율 대비 나린진과 네오헤스페리딘을 73.6%의 제거율로 2배 정도 감소시키는 모습을 보였다.In addition, as can be seen in Figure 3, naringinase derived from the Aspergillus oryzae NYO-2 strain has a removal rate of naringin and neohesperidin of 73.6% compared to the 40% removal rate shown in KTCC 6377 (the test strain). It seemed to decrease by about two-fold.
따라서 상업용 효소에서는 KN을, 식용 균주 아스퍼질러스 오리재 NYO-2 유래 효소를 활용하여 쓴맛을 효율적으로 감소시킬 수 있는 반응 조건에 대해 조사하였다.Therefore, reaction conditions that can efficiently reduce bitterness were investigated using KN in a commercial enzyme and an enzyme derived from the edible strain Aspergillus oryzae NYO-2.
1-3. 기질 선발을 위한 유자 시료별 효소처리1-3. Enzyme treatment for each citron sample for substrate selection
상기 실시예 1-1에서 TLC와 HPLC를 통해 선발된 효소를 이용해 다양한 유자시료와 효소반응하였다. 유자 시료는 유자청 고형물(유자청), 청유자 과피(청피), 황유자 과피(황피), 청유자 전체(청전체), 황유자 전체(황전체) 총 5가지를 동결건조 후 분말화한 것으로 진행하였으며, 각각의 유자 시료 분말 50 mg을 20 mM sodium-acetate 완충용액 0.9 mL로 용해시킨 뒤 효소를 최종농도 0.1%로 첨가시켜 24시간 반응하였다. 반응 후 0, 6, 12, 24시간 경과시 각각 분취하여, 나린진과 네오헤스페리딘의 함량을 비교하였다.Enzyme reactions were performed with various citron samples using the enzyme selected through TLC and HPLC in Example 1-1. Citron samples were made by freeze-drying and pulverizing a total of five types of yuzu fruit solids (citron extract), green citron peel (green skin), yellow citron peel (yellow skin), whole green citron (green whole), and whole yellow citron (yellow whole). 50 mg of each citron sample powder was dissolved in 0.9 mL of 20 mM sodium-acetate buffer solution, and then enzyme was added to a final concentration of 0.1% and reacted for 24 hours. Aliquots were collected at 0, 6, 12, and 24 hours after the reaction, and the contents of naringin and neohesperidin were compared.
(mg/g)Naringin
(mg/g)
(mg/g)Neohesperidin
(mg/g)
(mg/g)entire
(mg/g)
(%)removal rate
(%)
표 4 및 도 4에서 확인할 수 있듯이, KN 효소는 유자청, 청피, 황피, 청전체, 황전체에서 12시간 반응 후 쓴맛성분인 나린진과 네오헤스페리딘을 100.0%, 76.3%, 80.1%, 85.6%, 81.1% 제거하였다.As can be seen in Table 4 and Figure 4, KN enzyme removes bitter taste components naringin and neohesperidin by 100.0%, 76.3%, 80.1%, 85.6%, 81.1% after 12 hours of reaction in yujacheong, green bark, yellow bark, green whole body, and yellow whole body. % removed.
(mg/g)Naringin
(mg/g)
(mg/g)Neohesperidin
(mg/g)
(mg/g)entire
(mg/g)
(%)removal rate
(%)
도 4 및 표 5에서 확인할 수 있듯이, 아스퍼질러스 오리재 NYO-2 균주 유래 효소는 유자청 고형분, 청유자 과피, 황유자 과피, 청유자 전체, 황유자 전체에서 12시간 반응 후 쓴맛 성분인 나린진과 네오헤스페리딘을 100%, 90.6%, 73.2%, 68.7%, 79.8% 제거하였다.As can be seen in Figure 4 and Table 5, the enzyme derived from the Aspergillus oryzae NYO-2 strain is the bitter taste components naringin and neohesperidin after 12 hours of reaction in the solid content of citron citron, green citron peel, yellow citron peel, whole green citron, and whole yellow citron. 100%, 90.6%, 73.2%, 68.7%, 79.8% were removed.
1-4. 효소 반응 최적화1-4. Enzyme reaction optimization
KN 효소 및 아스퍼질러스 오리재 NYO2 균주 배양 상등액을 이용해 청유자 전체에 함유된 나린진과 네오헤스페리딘을 감소시키는 반응을 최적화하였다.The reaction to reduce naringin and neohesperidin contained in whole green citron was optimized using KN enzyme and Aspergillus oryzae NYO2 strain culture supernatant.
KN의 경우 효소 반응 조건은 기질 5%, 효소 0.1%, 12시간 반응을 기본으로 하여, 기질 농도, 효소 농도, 반응 시간만을 바꿔가며 최적화하였다. 반응 완료된 시료는 HPLC를 이용해 나린진과 네오헤스페리진 함량을 측정하였다.In the case of KN, the enzyme reaction conditions were based on 5% substrate, 0.1% enzyme, and 12-hour reaction, and were optimized by changing only the substrate concentration, enzyme concentration, and reaction time. The naringin and neohesperizin content of the reaction sample was measured using HPLC.
표 6, 도 5a 및 6a에서 확인할 수 있듯이, 효소 농도는 효소 반응액의 전체 농도에 대하여 0, 0.01, 0.025, 0.05, 0.075, 0.1, 0.25% 조건으로 사용하였으며, 0.1% 효소 첨가군에서 무처리군 대비 나린진과 네오헤스페리딘이 89.3% 감소하였다.As can be seen in Table 6 and Figures 5a and 6a, the enzyme concentration was used as 0, 0.01, 0.025, 0.05, 0.075, 0.1, and 0.25% of the total concentration of the enzyme reaction solution, and in the 0.1% enzyme addition group, untreated Naringin and neohesperidin decreased by 89.3% compared to the group.
표 7, 도 5b 및 6b에서 확인할 수 있듯이, 기질 농도는 시료를 0.1, 0.5, 1, 2.5, 5, 7.5, 10%로 녹여 사용하였으며, 5%를 녹였을 경우 나린진과 네오헤스페리딘이 각각 100% 제거되어 검출되지 않았다.As can be seen in Table 7 and Figures 5b and 6b, the substrate concentration was used by dissolving the sample at 0.1, 0.5, 1, 2.5, 5, 7.5, and 10%, and when 5% was dissolved, naringin and neohesperidin were each 100%. It was removed and not detected.
표 8, 도 5c 및 6c에서 확인할 수 있듯이, 반응 시간은 반응시킨 후 0, 1, 2, 3, 4, 6, 10, 12, 15, 24시간 경과 시 분취하여 확인하였으며, 12시간 이후에 반응했을 때 나린진과 네오헤스페리딘이 각각 81%의 제거율로 시간 대비 제거율이 가장 높아 12시간 이후가 효율적으로 감소함을 확인하였다.As can be seen in Table 8 and Figures 5c and 6c, the reaction time was confirmed by aliquoting 0, 1, 2, 3, 4, 6, 10, 12, 15, and 24 hours after reaction, and the reaction was conducted after 12 hours. When doing this, naringin and neohesperidin each had a removal rate of 81%. It was confirmed that the removal rate compared to time was the highest and was efficiently reduced after 12 hours.
효소 반응 조건은 NYO2의 경우 기질 5%, 효소 0.5%, 24시간 반응을 기준으로 두고, 기질 농도, 효소 농도, 반응 시간만을 바꿔가며 최적화하였다.For NYO2, the enzyme reaction conditions were based on 5% substrate, 0.5% enzyme, and 24-hour reaction, and were optimized by changing only the substrate concentration, enzyme concentration, and reaction time.
NYO2의 효소 농도는 효소 반응액의 최종 농도 0, 0.01, 0.025, 0.05, 0.075, 0.1, 0.25, 0.5, 1%로 사용하였다.The enzyme concentration of NYO2 was used at a final concentration of 0, 0.01, 0.025, 0.05, 0.075, 0.1, 0.25, 0.5, and 1% of the enzyme reaction solution.
표 9, 도 7a 및 8a에서 확인할 수 있듯이, 효소 농도를 0.5%로 수행했을 때 나린진과 네오헤스페리딘이 각각 0.13, 1.84 mg/g로 측정되어 88.2%의 제거율로서 무처리군과 효소처리군 대비 가장 효율적인 감소를 나타냈다.As can be seen in Table 9 and Figures 7a and 8a, when the enzyme concentration was set to 0.5%, naringin and neohesperidin were measured at 0.13 and 1.84 mg/g, respectively, resulting in a removal rate of 88.2%, the highest compared to the untreated group and the enzyme-treated group. showed an efficient reduction.
표 10, 도 7b 및 8b에서 확인할 수 있듯이, 기질 농도는 청유자 전체를 1, 2.5, 5, 6.5, 8.5, 10%로 녹여 사용하였으며, 5%를 녹였을 때, 나린진과 네오헤스페리딘이 각각 0.00, 1.67 mg/g로 첨가량 대비 대부분의 쓴맛 성분을 제거하는 것으로 나타났다.As can be seen in Table 10 and Figures 7b and 8b, the substrate concentration was used by dissolving the entire Cheongyuja at 1, 2.5, 5, 6.5, 8.5, and 10%, and when 5% was dissolved, naringin and neohesperidin were each 0.00. , 1.67 mg/g, which was found to remove most of the bitter ingredients compared to the added amount.
표 11, 도 7c 및 8c에서 확인할 수 있듯이, 반응 시간은 반응 후 0, 1, 2, 3, 4, 6, 8, 10, 12, 15, 24시간 때 분취하여 확인하였으며, 15시간 반응했을 때 나린진과 네오헤스페리딘이 각각 0.3, 2.26 mg/g으로 약 82.5%의 제거율로 가장 효율적으로 감소함을 확인하였다.As can be seen in Table 11 and Figures 7c and 8c, the reaction time was confirmed by aliquoting at 0, 1, 2, 3, 4, 6, 8, 10, 12, 15, and 24 hours after reaction, and when reacting for 15 hours It was confirmed that naringin and neohesperidin were reduced most efficiently at 0.3 and 2.26 mg/g, respectively, with a removal rate of about 82.5%.
따라서 효소 반응 조건은 KN 효소의 경우 기질 5%, 효소 0.1%, 12시간의 반응 조건, NYO2 균주 상등액의 경우 기질 5%, 효소 0.5%, 15시간의 반응 조건 적용 시 나린진, 네오헤스페리진이 효율적으로 감소됨을 확인하였다. 그 결과 KN 처리군 및 NYO2 처리군 모두 효소 반응 전의 나린진, 네오헤스페리딘 함량에 비해서 80% 이상 감소함을 보였다. 따라서 청유자 전체 분말에 KN 효소 및 NYO2 균주 상등액을 반응시켜 쓴맛이 저감된 유자 분말을 제조하였으며, 소재 특성과 효능 평가를 진행하였다.Therefore, the enzyme reaction conditions are 5% substrate, 0.1% enzyme, and 12 hours for the KN enzyme, and 5% substrate, 0.5% enzyme, and 15 hours for the NYO2 strain supernatant. When applying the reaction conditions, naringin and neohesperizin are efficient. It was confirmed that it was reduced to . As a result, both the KN-treated group and the NYO2-treated group showed a decrease of more than 80% compared to the naringin and neohesperidin content before the enzyme reaction. Therefore, citron powder with reduced bitterness was prepared by reacting whole green citron powder with KN enzyme and NYO2 strain supernatant, and material properties and efficacy were evaluated.
실시예 2: 쓴맛이 저감된 유자 분말의 특성 조사Example 2: Investigation of properties of citron powder with reduced bitterness
2-1. 유자 분말의 품질 특성2-1. Quality characteristics of citron powder
청유자(Green Yuzu) 또는 황유자(Yellow Yuzu) 전체를 동결건조하여 제조한 분말에 대하여 KN 효소 처리와 NYO2 균주 배양 상등액 처리한 효소반응물 전체를 동결건조후 분말의 모습을 촬영하여 분석하였다.Powder prepared by freeze-drying whole green yuzu or yellow yuzu was analyzed by photographing the powder after freeze-drying the entire enzyme reaction product treated with KN enzyme and NYO2 strain culture supernatant.
도 9a 및 9b에서 확인할 수 있듯이, NYO2 균주 배양 상등액 처리군에서 노란색이 증가하는 모습을 나타냈다.As can be seen in Figures 9a and 9b, the yellow color increased in the NYO2 strain culture supernatant treatment group.
이어서 청유자 및 황유자 분말에 대한 효소 처리군 시료 1 g을 증류수에 10%(v/v)로 용해시킨 후 pH, 산도, 당도, 색도를 측정하여 비교하였다.Next, 1 g of enzyme-treated samples of green citron and yellow citron powder were dissolved in distilled water at 10% (v/v), and the pH, acidity, sugar content, and color were measured and compared.
pH는 pH 미터(Benchtop pH Meter, MettlerToledo, Columbus, OH, USA)로 용해시킨 시료를 측정하였다.pH was measured in dissolved samples using a pH meter (Benchtop pH Meter, MettlerToledo, Columbus, OH, USA).
산도는 시료에 1%(v/v) 페놀프탈레인(phenolphthalein)(Junsei chemical Co., Ltd.,Tokyo, Japan)을 2-3방울을 넣은 후 0.1 N NaOH(Sigma-Aldrich, St.Louis, MO, USA)를 이용해 적정하여 NaOH 소비량을 측정한 후 시료의 총 산도를 시트르산(citric acid)(Sigma-Aldrich, St.Louis, MO, USA) 기준으로 환산하였다.Acidity was measured by adding 2-3 drops of 1% (v/v) phenolphthalein (Junsei chemical Co., Ltd., Tokyo, Japan) to the sample and then adding 0.1 N NaOH (Sigma-Aldrich, St.Louis, MO, After measuring NaOH consumption by titration using (USA), the total acidity of the sample was converted to citric acid (Sigma-Aldrich, St.Louis, MO, USA).
당도는 굴절당도계(Digital handheld PAL-1, ATAGO Co., Ltd, Tokyo, Japan)로 용해시킨 시료를 측정하였다.Sugar content was measured in dissolved samples using a refractometer (digital handheld PAL-1, ATAGO Co., Ltd, Tokyo, Japan).
색도는 색차계(Handheld color spectrophotometer 45/0 NS 800, Shenzhen 3nh Technology Co., Ltd, Shenzhen, China)를 이용해, L(Lightness), a(Redness), b(yellowness), ΔE(Total colordifference)를 측정하였다.Chromaticity was measured using a colorimeter (Handheld color spectrophotometer 45/0 NS 800, Shenzhen 3nh Technology Co., Ltd, Shenzhen, China), L (Lightness), a (Redness), b (yellowness), and ΔE (Total color difference). Measured.
(%)acidity
(%)
(Brix)Sugar content
(Brix)
표 12에서 확인할 수 있듯이, pH는 KN 효소 또는 NYO2 균주 배양 상등액 처리군에서 무처리군에 비해 증가하는 모습을 나타냈으며 특히 청유자에 대한 NYO2 균주 배양 상등액 처리군에서는 20% 이상 상승하였다. 당도는 효소 처리 시 증가하는 경향을 나타냈으며, 셀룰로오스(cellulose), 헤미셀룰로오스(hemicellulose)분해에 의해 당 성분들이 유리되었기 때문으로 판단되었다. 색도는 효소 처리 시 황색도(b)가 증가하였으며, 전체적으로 기호도가 상승된 쓴맛 저감 유자 분말이 생성되었다.As can be seen in Table 12, pH showed an increase in the group treated with KN enzyme or NYO2 strain culture supernatant compared to the untreated group, and in particular, it increased by more than 20% in the group treated with NYO2 strain culture supernatant for Cheongyuja. Sugar content tended to increase upon enzyme treatment, and it was believed that this was because sugar components were liberated through decomposition of cellulose and hemicellulose. The color yellowness ( b ) increased upon enzyme treatment, and bitterness-reduced citron powder with increased overall preference was produced.
2-2. 식이섬유 함량 분석2-2. Dietary fiber content analysis
상업용 효소와 고유균주 유래의 효소는 나린진과 네오헤스페리딘을 비배당화 시키는 효소 이외에도 다양한 효소가 존재하는데, 그 중에서 식이섬유 구조 변화에 관련되는 효소 또한 내포하고 있다.Commercial enzymes and enzymes derived from native bacteria include a variety of enzymes in addition to enzymes that deglycosylate naringin and neohesperidin, and among them, enzymes related to structural changes in dietary fiber are also included.
식이섬유의 함량 측정을 위하여 산성 세제 불용성 섬유(Acid detergent fiber; ADF), 중성 세제 불용성 섬유(Neutral detergent fiber; NDF), 리그닌(Lignin), 펙틴(pectin)을 측정하였다. 시료 0.5 g을 200 mL 산성계면활성용액과 200 mL 중성계면활성용액에 혼합하여 100℃에서 1시간 여과하고, 물(90℃) 40 mL와 아세톤(acetone) 40 mL를 이용해 잔사의 색이 없어질 때까지 세척한 후 105℃에서 12시간 건조하고, 무게를 측정하였다.To measure the content of dietary fiber, acid detergent fiber (ADF), neutral detergent fiber (NDF), lignin, and pectin were measured. Mix 0.5 g of sample with 200 mL of acidic surfactant solution and 200 mL of neutral surfactant solution, filter at 100°C for 1 hour, and use 40 mL of water (90°C) and 40 mL of acetone to remove the color of the residue. After washing until dry, it was dried at 105°C for 12 hours and its weight was measured.
ADF와 NDF는 잔사의 무게에서 시료의 무게를 나눠서 계산하였다. 리그닌은 시료 0.5 g에 72% 황산 15 mL를 가해 2시간 동안 혼합한 뒤 증류수 356 mL를 가해 황산을 3%까지 희석했다. 98℃에서 3시간 여과하고 뜨거운 물 150 mL로 세척한 뒤 105℃의 오븐에서 건조 후 무게를 측정하였다. 리그닌은 침전물의 무게를 시료의 무게로 나눠서 계산하였고, 셀룰로오스는 ADF와 리그닌의 함량 차이로 계산하였으며, 헤미셀룰로오스는 NDF와 ADF의 함량 차이로 계산하였다. 펙틴은 펙틴 키트(pectin kit, pectinidentification kit, Megazyme, Ireland)를 이용해 측정하였으며 검량곡선은 감귤류에서 추출한 저에스테르 펙틴(low ester pectin)을 사용하였다.ADF and NDF were calculated by dividing the weight of the sample by the weight of the residue. For lignin, 15 mL of 72% sulfuric acid was added to 0.5 g of the sample, mixed for 2 hours, and then 356 mL of distilled water was added to dilute the sulfuric acid to 3%. It was filtered at 98°C for 3 hours, washed with 150 mL of hot water, dried in an oven at 105°C, and then weighed. Lignin was calculated by dividing the weight of the sediment by the weight of the sample, cellulose was calculated as the difference in content between ADF and lignin, and hemicellulose was calculated as the difference in content between NDF and ADF. Pectin was measured using a pectin kit (pectin identification kit, Megazyme, Ireland), and the calibration curve used low ester pectin extracted from citrus fruits.
표 13에서 확인할 수 있듯이, 식이섬유 분석결과 청유자, 황유자 모두 총 식이섬유(total dietary fiber; TDF)의 함량은 크게 변하지 않았지만 수용성식이섬유(soluble dietary fiber; SDF)는 증가하는 경향을 나타냈고, 불용성식이섬유(insoluble dietary fiber; IDF)는 감소하는 경향을 나타냈다.As can be seen in Table 13, as a result of dietary fiber analysis, the total dietary fiber (TDF) content of both green citron and yellow yuja did not change significantly, but soluble dietary fiber (SDF) tended to increase. Insoluble dietary fiber (IDF) showed a tendency to decrease.
특히 황유자에 대한 NYO2 균주 배양 상등액 처리군에서 IDF가 33% 이상 감소하는 모습을 보였으며, SDF의 경우 25% 이상 증가하였다. 청유자보다 황유자가 식이섬유 함유량이 3배 높았으며, 수용성과 불용성 식이섬유 비율은 무처리군 대비 KN 효소 또는 NY02 균주 배양 상등액 처리군에서 각각 청유자에서는 24% 및 45%가 증가하였으며 황유자에서는 각각 42% 및 77% 증가되었다.In particular, in the group treated with NYO2 strain culture supernatant for yellow citron, IDF showed a decrease of more than 33%, and in the case of SDF, it increased by more than 25%. The dietary fiber content of yellow yuja was three times higher than that of green yuja, and the ratio of soluble and insoluble dietary fiber increased by 24% and 45% in green yuja and 45% in yellow yuja, respectively, in the KN enzyme or NY02 strain culture supernatant treatment group compared to the untreated group, respectively. increased by 42% and 77%.
표 14에서 확인할 수 있듯이, 식이섬유의 구성성분인 셀룰로오스, 헤미셀룰로오스, 리그닌, 펙틴은 청유자 및 황유자 전체 분말에 대한 KN 효소 또는 NYO2 균주 배양 상등액 처리군에서 모두 감소하는 경향을 나타냈다. 특히 전체 식이섬유가 KN 효소 또는 NYO2 균주 배양 상등액 처리군에서 각각 청유자는 32% 및 40% 감소하였으며 황유자는 22%, 48% 감소하였다. 성분 중에서는 불용성 식이섬유인 셀룰로오스, 헤미셀룰로오스가 크게 감소하여 수용성이 향상되었다.As can be seen in Table 14, cellulose, hemicellulose, lignin, and pectin, which are components of dietary fiber, all tended to decrease in the KN enzyme or NYO2 strain culture supernatant treatment group for whole green citron and yellow citron powder. In particular, total dietary fiber decreased by 32% and 40% for green citron, and 22% and 48% for yellow citron, respectively, in the group treated with KN enzyme or NYO2 strain culture supernatant. Among the ingredients, the insoluble dietary fibers cellulose and hemicellulose were greatly reduced, improving water solubility.
2-3. 유리당 함량 분석2-3. Free sugar content analysis
효소 반응이 일어난 후 셀룰로오스, 헤미셀룰로오스의 결합이 끊어지고, 세포벽이 허물어지면서 구성하고 있던 글루코스, 자일로스(Xylose), 갈락투론산, 프럭토스가 유리되었다. 이는 식이섬유 함량 분석에서 셀룰로오스, 헤미셀룰로오스 함량의 감소와도 유사한 양상을 나타냈다. 또한 FT-IR에서 셀룰로오스, 헤미셀룰로오스, 리그닌의 분해와 같은 맥락으로 미루어 볼 수 있다.After the enzyme reaction occurred, the bonds between cellulose and hemicellulose were broken, and the cell wall collapsed, releasing glucose, xylose, galacturonic acid, and fructose. This showed a similar pattern to the decrease in cellulose and hemicellulose content in the dietary fiber content analysis. Additionally, it can be viewed in the same context as the decomposition of cellulose, hemicellulose, and lignin in FT-IR.
청유자 황유자 분말에 대하여 효소 반응 후 함유된 유리당을 측정하기 위하여 1216 Infinity LC (Agilent Technologies, Inc., Santa Clara, CA, USA)를 사용하여 측정하였다. 컬럼으로는 Carbohydrate(5 μm, 4.6 X 250 mm; gilent Technologies, Inc., Santa Clara, CA, USA))을 사용하였고, 이동상 용매로는 증류수에 인산을 0.1% 혼합한 물을 사용하였다. 컬럼 오븐 온도 40℃, 주입량 10 μL, 유속 0.6 mL/min을 유지한 상태에서 45분간 측정하였고, 표준물질은 갈락투론산, 글루코스, 프럭토스, 수크로스, 아라비노스를 사용하였다. 검출기로는 RID-10A (Agilent Technologies, Inc., Santa Clara, CA, USA)를 사용하였다.In order to measure the free sugars contained in green citron and yellow citron powder after enzyme reaction, 1216 Infinity LC (Agilent Technologies, Inc., Santa Clara, CA, USA) was used. Carbohydrate (5 μm, 4.6 The measurement was performed for 45 minutes while maintaining the column oven temperature of 40°C, injection volume of 10 μL, and flow rate of 0.6 mL/min, and galacturonic acid, glucose, fructose, sucrose, and arabinose were used as standard substances. RID-10A (Agilent Technologies, Inc., Santa Clara, CA, USA) was used as a detector.
acidGlalacturonic
acid
표 15에서 확인할 수 있듯이, 나린진과 네오헤스페리딘의 배당 성분인 글루코스, 람노오스(rhamnose)가 유리당으로 검출되었다. 수크로스는 효소 반응에 의해 청유자 및 황유자에서 모두 감소하는 모습을 보였다. 특히 청유자에 대한 KN 효소 처리군은 람노오스에 대하여 3.61 mg/g으로 가장 많이 분해되었으며, 글루코스 역시 무처리군에 비해 1.7배 상승하는 모습을 보였다.As can be seen in Table 15, glucose and rhamnose, which are dividend components of naringin and neohesperidin, were detected as free sugars. Sucrose showed a decrease in both green citron and yellow yuja due to an enzyme reaction. In particular, the KN enzyme-treated group of green citron decomposed the most rhamnose at 3.61 mg/g, and glucose also showed a 1.7-fold increase compared to the untreated group.
청유자와 황유자의 유리당 함량은 효소 처리군에서 전체적으로 30-40% 증가하였으며 특히 나린진과 네오헤스페리딘에서 분해되어 나오는 람노오스가 크게 증가하였다. 헤미셀룰로오스가 분해되어 자일로스와 글루코스가 증가하였으며 펙틴이 분해되어 갈락트로닉산이 생성됨을 확인하였다.The free sugar content of green citron and yellow citron increased by 30-40% overall in the enzyme treatment group, and in particular, rhamnose produced by decomposition from naringin and neohesperidin increased significantly. It was confirmed that hemicellulose was decomposed, xylose and glucose increased, and pectin was decomposed to produce galactronic acid.
2-4. 쓴맛 성분 변화 분석2-4. Analysis of changes in bitter taste components
전자혀는 7가지 센서(CTS= 짠맛; PKS= 단맛; NMS= 감칠맛; ANS= 쓴맛; AHS=신맛; 보조인자= CPS, SCS)를 가진다. 유자의 쓴맛을 나타내는 성분에는 나린진과 네오헤스페리딘을 제외하고도 다양한 성분을 가지고 있으며, 쓴맛은 한가지 센서만으로 판단하기 어렵다.The electronic tongue has 7 sensors (CTS = salty; PKS = sweet; NMS = umami; ANS = bitter; AHS = sour; cofactors = CPS, SCS). Aside from naringin and neohesperidin, the bitter taste of citron contains a variety of ingredients, and it is difficult to judge bitterness with just one sensor.
따라서 CON에 나린진을 0.1, 0.25, 0.5% 농도별로 첨가해 나린진 기준의 쓴맛을 새로운 센서로 추가하였다. 센서는 화학적으로 성분을 측정하는 것이 아닌, 시료의 전체적인 맛을 감지하여 각각의 센서 감응도를 0-10의 범위 내에서 나타내었다. Therefore, naringin was added to CON at different concentrations of 0.1, 0.25, and 0.5%, and bitterness based on naringin was added using a new sensor. Rather than chemically measuring ingredients, the sensor detected the overall taste of the sample and displayed each sensor's sensitivity within the range of 0-10.
전자혀 분석은 유자 분말 5g을 증류수에 5% 농도로 녹인 후 100 mL 용액을 전자혀(Astree2, Alpha MOS, Toulouse, France)를 이용하여 120초간 측정하였다. 시료마다 5회 반복하여 측정하였으며, 각 시료의 맛 성분 패턴 분석은 Alpha MOS사에서 제공된 프로그램 AlphaSoft 17 ver.(Alpha MOS, Toulouse, France)을 사용하여 판별함수 분석(discriminant function analysis, DFA)을 통해 도출하였다.For electronic tongue analysis, 5 g of citron powder was dissolved in distilled water at a 5% concentration, and then 100 mL of the solution was measured for 120 seconds using an electronic tongue (Astree2, Alpha MOS, Toulouse, France). Measurements were repeated five times for each sample, and the taste component pattern of each sample was analyzed through discriminant function analysis (DFA) using the program AlphaSoft 17 ver. (Alpha MOS, Toulouse, France) provided by Alpha MOS. Derived.
그 결과 청유자와 황유자 모두 무처리군에 비해 KN 효소 또는 NYO2 균주 배양 상등액 처리군에서 나린진 기준의 쓴맛은 줄어들고, 전체적으로 풍부해진 맛이 되었다. 특히 NYO2 균주 배양 상등액 처리군은 KN 효소 처리에 비해 감칠맛, 신맛, 짠맛 등이 상승하여 관능적으로 우수해진 것으로 판단된다.As a result, the bitter taste based on naringin was reduced in the group treated with KN enzyme or NYO2 strain culture supernatant for both green citron and yellow citron compared to the untreated group, and the overall taste became richer. In particular, the NYO2 strain culture supernatant treatment group was judged to be superior in terms of sensory quality, with increased umami, sourness, and salty taste compared to the KN enzyme treatment group.
표 16, 도 10a, 10b 및 11에서 확인할 수 있듯이, 전자혀를 이용해 나린진을 기준으로 쓴맛의 감소 정도를 분석한 결과, 청유자에서는 무처리군 대비 KN 효소 처리군에서는 5.0%, NY02 균주 배양 상등액 처리군에서는 2.9%의 쓴맛만 남았다. 또한 황유자에서는 무처리군 대비 KN 효소 처리군에서는 15.4%, NY02 균주 배양 상등액 처리군에서는 2.5%의 쓴맛을 나타내었다.As can be seen in Table 16 and Figures 10a, 10b, and 11, as a result of analyzing the degree of reduction in bitterness based on naringin using electronic tongue, in Cheongyuja, 5.0% in the KN enzyme-treated group compared to the untreated group, and NY02 strain culture supernatant. In the treatment group, only 2.9% bitterness remained. In addition, yellow citron showed a bitter taste of 15.4% in the KN enzyme treated group and 2.5% in the NY02 strain culture supernatant treated group compared to the untreated group.
대체로 청유자는 황유자 대비 4배의 쓴맛을 나타냈으며 이는 나린진 845 mg에 해당되는 쓴맛임을 알 수 있다.In general, green citron was four times more bitter than yellow citron, which can be seen to be equivalent to 845 mg of naringin.
2-5. 효소처리된 유자 분말의 물리적 특징 조사2-5. Investigation of physical characteristics of enzyme-treated citron powder
2-5-1. 입자 크기 분석2-5-1. Particle size analysis
입자 크기 및 분산도를 조사하기 위해 나노입자크기분석기(오츠카 전자(주)의 ELSZ-2000ZS)를 사용하여 측정하였다. 청유자 및 황유자 분말을 증류수에 0.1% 용해하여 셀(cell)에 2 mL를 넣고 25℃에서 3번 반복 측정하였다.To investigate particle size and dispersion, it was measured using a nanoparticle size analyzer (ELSZ-2000ZS, Otsuka Electronics Co., Ltd.). Blue citron and yellow citron powder were dissolved at 0.1% in distilled water, 2 mL was added to a cell, and measurements were repeated three times at 25°C.
무처리군에 비해 청유자, 황유자에 대한 KN 효소 또는 NYO2 균주 배양 상등액 처리군은 분산도를 낮추고 입자의 크기를 작게 만들었다. 특히 황유자의 경우 무처리군에 비해 NYO2 균주 배양 상등액 처리군에서 입자 크기가 80%이상 감소함을 나타냈다. 입자 크기가 줄어들 경우 수용액과 표면적이 증가하여 용해도가 향상되고, 수용성이 증가하게 된다.Compared to the untreated group, the group treated with KN enzyme or NYO2 strain culture supernatant for green citron and yellow citron lowered the dispersion degree and made the particle size smaller. In particular, in the case of yellow yuja, the particle size was reduced by more than 80% in the NYO2 strain culture supernatant treated group compared to the untreated group. When the particle size is reduced, the aqueous solution and surface area increase, improving solubility and increasing water solubility.
표 17, 도 12a 및 12b에서 확인할 수 있듯이, 무처리군 대비 효소 처리군에서 황유자 및 청유자 모두의 입자 크기가 줄어들고 분산도는 늘었으며, 특히 입자들의 크기가 10배 이상 줄어들어 작은 입자들이 생성되므로 PDI 값이 0 내지 1의 값을 나타냈다. 이 경우 단분산으로 입자의 크기가 균일함을 의미한다.As can be seen in Table 17 and Figures 12a and 12b, the particle size of both yellow and blue citron decreased and the dispersion increased in the enzyme-treated group compared to the untreated group. In particular, the size of the particles was reduced by more than 10 times, producing small particles. The PDI value ranged from 0 to 1. In this case, monodisperse means that the particle size is uniform.
2-5-2. FTIR 분석2-5-2. FTIR analysis
청유자 및 황유자에서 KN 효소 또는 NYO2 균주 배양 상등액 처리에 따른 구조 변화를 조사하기 위해 FTIR(Fourier transform infra-red spectroscopy, perkin Elmer Spectrum 400)로 조사하였다. 헤미셀룰로오스, 셀룰로오스, 리그닌 등의 변화에 따라 해당 주파수(3411, 3927, 1730, 1029)의 투과도가 변하게 되는데, 3411, 2927, 1730, 1029 cm-1 은 각각 셀룰로오스, 헤미셀룰로오스 결정 영역에서 -OH기의 분자내 수소결합, 셀룰로오스의 -OH 수소결합으로 -OH가 붕괴될 시 피크 감소, 헤미셀룰로오스의 아세틸(acetyl) 및 우로닉 에스테르 그룹(uronic ester groups), 리그닌 또는 헤미셀룰로오스의 피라노오스(pyranose) 고리에서 C-O-C의 C-O를 의미하며 감소 시 리그닌과 헤미셀룰로오스의 분해를 나타낸다.To investigate structural changes in blue citron and yellow yuja due to treatment with KN enzyme or NYO2 strain culture supernatant, FTIR (Fourier transform infra-red spectroscopy, perkin Elmer Spectrum 400) was used. The transmittance at the corresponding frequency (3411, 3927, 1730, 1029) changes according to changes in hemicellulose, cellulose, lignin, etc., and 3411, 2927, 1730, and 1029 cm -1 are -OH molecules in the cellulose and hemicellulose crystal regions, respectively. Internal hydrogen bonding, peak reduction when -OH collapses due to -OH hydrogen bonding of cellulose, acetyl and uronic ester groups of hemicellulose, COC in lignin or pyranose ring of hemicellulose It means CO and when reduced, it indicates the decomposition of lignin and hemicellulose.
펙틴 분말에 대하여 FTIR 분광광도계(spectrophotometer)(Frontier-89063; PerkinElmer, Inc., Waltham, USA)와 MIR TGS detector를 활용하여 작용기의 변화를 분석하였으며, 측정파장은 500-4000cm-1으로 분석하였다.Pectin powder was analyzed for changes in functional groups using a FTIR spectrophotometer (Frontier-89063; PerkinElmer, Inc., Waltham, USA) and a MIR TGS detector, and the measurement wavelength was 500-4000 cm -1 .
도 13에서 확인할 수 있듯이, 전체적으로 황유자와 청유자 모두 KN 효소보다 NYO2 균주 상등액 처리군에서 식이섬유의 변화량이 큼을 보였으며, 불용성 식이섬유인 셀룰로오스, 헤미셀룰로오스, 리그닌이 분해되어 더 많이 감소함을 나타냈다.As can be seen in Figure 13, overall, the amount of change in dietary fiber was greater in the NYO2 strain supernatant treatment group than in the KN enzyme for both yellow citron and green citron, and insoluble dietary fibers such as cellulose, hemicellulose, and lignin were decomposed and decreased more.
2-5-3. 주사전자현미경을 이용한 표면분석2-5-3. Surface analysis using a scanning electron microscope
청유자 또는 황유자 기질 5% 조건하에서 효소 반응 후 실활, 동결건조 후 주사전자현미경(Scanning Electron Microscope; SEM)을 통해 표면을 확인하였다. SEM은 시료 표면에 전자선을 주입해 시료 표면의 입체구조를 확인할 수 있다.After enzymatic reaction under 5% green citron or yellow citron substrate conditions, deactivation and freeze-drying were performed, and the surface was confirmed using a scanning electron microscope (SEM). SEM can confirm the three-dimensional structure of the sample surface by injecting electron beams into the sample surface.
미세구조는 전계방사형 주사전자현미경(field emission scanning electron microscope, FE-SEM, Gemini 500, Zeiss, Oberkochen, Germany)으로 관찰하였다. 건조상태인 시료를 백금 코팅 후 가속전압 15 kV, 400배 배율에서 관찰하였다.Microstructure was observed using a field emission scanning electron microscope (FE-SEM, Gemini 500, Zeiss, Oberkochen, Germany). The dry sample was coated with platinum and observed at an acceleration voltage of 15 kV and 400x magnification.
도 14에서 확인할 수 있듯이, 무처리(control)군과 효소 처리군의 분말 입자 형태를 비교해 보았을 때, 무처리군은 표면이 매끄럽지만 효소 처리군에서는 다공성의 모습을 보였다. 다공성의 모습을 띌 경우, 수분 보유력이 상승하게 되고, 효소 처리에 의해 유자의 세포벽 구조가 파괴됨에 따라 세포벽에 결합되어 있던 플라보노이드가 유리되어 기능성 식이섬유로 변화함을 의미한다.As can be seen in Figure 14, when comparing the shape of the powder particles of the untreated (control) group and the enzyme-treated group, the surface of the untreated group was smooth, but the surface of the enzyme-treated group was porous. If it takes on a porous appearance, the moisture retention capacity increases, and as the cell wall structure of the citron is destroyed by enzyme treatment, the flavonoids bound to the cell wall are released and transformed into functional dietary fiber.
한편 KN 효소 또는 NYO2 균주 배양 상등액 처리군에서 구멍의 모습은 서로 상이한 모습을 나타냈는데, KN 효소 처리군에서의 표면의 구멍이 규칙적이라면, NYO2 균주 배양 상등액 처리군에서는 구멍이 불규칙적으로 뚫려 있는 모습을 보였다.On the other hand, the appearance of the holes in the KN enzyme or NYO2 strain culture supernatant treatment group showed a different appearance. If the surface pores in the KN enzyme treatment group were regular, the holes in the NYO2 strain culture supernatant treatment group showed irregular holes. It seemed.
실시예 3: 기능성 유자 분말의 제형 안정성Example 3: Formulation stability of functional citron powder
수분보유력(Water holding capacity; WHC), 유지보유력은(oil holding capacity; OHC)는 식이섬유의 질과 밀접한 관련이 있다. 수분보유력이 높은 식이섬유는 많은 수분을 함유할 수 있어 장운동을 촉진시키고, 유지보유력이 높은 식이섬유는 고지방 식품을 안정적으로 유지시켜 유통기한을 연장하는 데 기여한다.Water holding capacity (WHC) and oil holding capacity (OHC) are closely related to the quality of dietary fiber. Dietary fiber with high water retention capacity can contain a lot of moisture and promotes bowel movements, and dietary fiber with high water retention capacity keeps high-fat foods stable and contributes to extending their shelf life.
수분보유력을 측정하기 위하여 건조시료 0.5 g을 물 10 mL과 혼합한 뒤(1:20, w/v) 25℃에서 24시간 동안 정치했다. 원심분리기(Combi 514R, Hanil Scientific Inc. Gimpo, Korea)를 이용해 4000 X g로 15분간 원심분리 후 상등액을 제외한 침전물의 무게를 측정하여 아래의 식을 이용해 수분보유력을 측정하였다.To measure moisture retention, 0.5 g of dried sample was mixed with 10 mL of water (1:20, w/v) and left at 25°C for 24 hours. After centrifugation at 4000
수분보유력(WHC)(g/g)= (WwetWdry)/Wdry Water retention capacity (WHC) (g/g)= (W wet W dry )/W dry
유지보유력(Oil holding capacity; OHC)을 측정하기 위하여 건조시료 0.5 g을 올리브유 5 mL과 혼합(1:10, w/v)한 뒤 4℃에서 1시간 동안 정치해 두었다. 그 후 4000 X g로 15분간 원심분리하여 상등액을 제외한 침전물의 무게를 측정하였다. 유지보유력은 아래의 식을 이용해 측정하였다.To measure oil holding capacity (OHC), 0.5 g of dried sample was mixed with 5 mL of olive oil (1:10, w/v) and left at 4°C for 1 hour. Afterwards, it was centrifuged at 4000 The retention capacity was measured using the formula below.
유지보유력(OHC)(g/g)= (WpelletWdry)/Wdry Retention capacity (OHC) (g/g)= (W pellet W dry )/W dry
팽윤력(Swelling capacity; SC)를 측정하기 위하여 건조시료 0.5 g을 물 10 mL과 혼합(1:20, w/v)한 뒤 4℃에서 18시간 정치해 두었다. 시료가 차치하는 부피를 측정한 뒤 아래의 식을 이용해 팽윤력을 계산하였으며, Vwet은 수화 된 시료의 부피, Vdry는 건조시료의 부피, Wdry는 건조시료의 질량이다.To measure swelling capacity (SC), 0.5 g of dried sample was mixed with 10 mL of water (1:20, w/v) and left at 4°C for 18 hours. After measuring the volume occupied by the sample, the swelling power was calculated using the formula below, where V wet is the volume of the hydrated sample, V dry is the volume of the dry sample, and W dry is the mass of the dry sample.
팽윤력(SC)(mL/g)= (VwetVdry)/Wdry Swelling power (SC) (mL/g)= (V wet V dry )/W dry
용해도를 측정하기 위하여 시료 0.5 g에 물 10 mL를 넣고 60 rpm으로 60분간 반응시킨 후, 4000 X g에서 15분간 원심분리시켜 상등액은 버린 후 침전물을 105℃에서 건조시켜 무게를 측정하였다. 아래의 식을 통해 용해도를 계산하였으며, Wdry는 건조 후시료의 무게, Wsample은 시료무게를 나타냈다.To measure solubility, 10 mL of water was added to 0.5 g of the sample, reacted at 60 rpm for 60 minutes, centrifuged at 4000 Solubility was calculated using the formula below, where W dry represents the weight of the sample after drying and W sample represents the sample weight.
용해도(%)= (1Wdry/Wsample) X 100Solubility (%)= (1W dry /W sample )
청유자와 황유자 모두 효소 처리군에서 수분보유력과 유지보유력이 증가하는 경향을 나타냈으며, 특히 청유자에 대한 NYO2 균주 배양 상등액 처리군에서 수분보유력은 5.50 g/g으로 가장 높은 값을 나타냈다. 이는 팽윤력과도 밀접한 관련이 있으며, 청유자에 대한 NYO2 균주 배양 상등액 처리군의 경우 20%이상 상승하여 가장 높은 팽윤력을 나타냈다. 유지보유력은 청유자, 황유자 모두 무처리군에 비해 2배 이상 상승함을 보였다. 용해도는 무처리군에 비해 NYO2 균주 배양 상등액 처리군에서 5배 이상 상승한 모습을 보였는데, 이는 물에 잘 수화되며, 생체 이용률이 크게 항상되었을 가능성을 시사한다.Both Cheongyuja and Hwangyuja showed a tendency to increase water retention and oil retention capacity in the enzyme-treated group. In particular, the water retention capacity of the NYO2 strain culture supernatant treatment group for Cheongyuja showed the highest value of 5.50 g/g. This is closely related to swelling power, and the group treated with NYO2 strain culture supernatant for green citron showed the highest swelling power, rising by more than 20%. The retention capacity of both blue citrus and yellow yuja showed an increase of more than two times compared to the untreated group. The solubility showed a more than 5-fold increase in the NYO2 strain culture supernatant treated group compared to the untreated group, which suggests that it is well hydrated in water and the bioavailability may have been greatly increased.
실시예 4: 유자 분말의 다이어트 효능 평가Example 4: Evaluation of diet efficacy of citron powder
4-1. 세포독성평가4-1. Cytotoxicity evaluation
전지방세포 3T3-L1를 이용해 시료의 독성 조사를 수행하였으며, 구체적으로 Oil red O 실험을 통해 축적된 지방 함량 조사 실험, 및 분해된 지방세포에서 유리된 글리세롤(glycerol) 함량 조사 실험을 수행하여 따라서 다른 시험법에 따라 유자시료들의 농도별 독성조사를 수행하였다.A toxicity study on the sample was conducted using pre-adipocytes 3T3-L1. Specifically, an experiment was conducted to investigate the accumulated fat content through an Oil red O experiment, and an experiment to examine the glycerol content liberated from decomposed adipocytes was performed. Toxicity studies were conducted by concentration of citron samples according to different test methods.
본 실험에서 사용한 마우스 유래 전지방세포주 3T3-L1은 American type culture collection(ATCC, Manassas, Virginia, USA)에서 구입하여 사용하였다. 3T3-L1 세포주는 10% BCS와 1% p/s을 첨가한 DMEM에서 37℃, 5% CO2 조건으로 배양하였고, 세포가 70% 이상 자랐을 때 계대배양하였다.The mouse-derived preadipocyte cell line 3T3-L1 used in this experiment was purchased from the American type culture collection (ATCC, Manassas, Virginia, USA). The 3T3-L1 cell line was cultured in DMEM supplemented with 10% BCS and 1% p/s at 37°C and 5% CO 2 , and subcultured when the cells grew to more than 70%.
3T3-L1 세포의 분화를 위해 세포를 24 웰 플레이트(well plate)에 2 X 104 cells/well로 총 용적이 1 mL이 되도록 분주한 후 96시간 동안 배양하며 90% 이상 자라도록 했다. 96시간 후 differentiation medium (DMEM + 10% FBS + 0.5 mM IBMX + 1 μM dexamethasone + 1 μg/mL insulin)으로 배지를 교체한 후 72시간 동안 배양하여 분화가 시작되도록 하였다. 이후 adipocyte maintenance medium (DMEM + 10% FBS + 1 μg/mL insulin)을 처리한 후 72시간 동안 배양하였다. 마지막으로 terminal differentiation medium (DMEM + 10% FBS)를 처리하여 72시간 동안 배양하여 전지방세포로부터 지방세포로의 분화를 완료하였다.For differentiation of 3T3-L1 cells, the cells were distributed in a 24- well plate at 2 After 96 hours, the medium was replaced with differentiation medium (DMEM + 10% FBS + 0.5 mM IBMX + 1 μM dexamethasone + 1 μg/mL insulin) and cultured for 72 hours to initiate differentiation. Afterwards, the cells were treated with adipocyte maintenance medium (DMEM + 10% FBS + 1 μg/mL insulin) and cultured for 72 hours. Finally, the cells were treated with terminal differentiation medium (DMEM + 10% FBS) and cultured for 72 hours to complete differentiation from preadipocytes to adipocytes.
3T3-L1 세포에서 시료의 세포 독성을 측정하기 위해 water-soluble tetrazolium (WST) assay를 진행하였다. 24 웰 플레이트에 2 X 104 cells/well로 총 용적이 1 mL이 되도록 세포를 분주하여 분화를 진행하였다. 이때 지방 생성 억제 모델에서의 세포 독성 평가를 위해서는 differentiation medium 처리 시부터 다양한 농도(0-250 μg/mL)의 시료를 처리하였다.To measure the cytotoxicity of samples in 3T3-L1 cells, water-soluble tetrazolium (WST) assay was performed. Differentiation was performed by distributing cells in a 24 - well plate at 2 At this time, in order to evaluate cytotoxicity in the adipogenesis inhibition model, various concentrations (0-250 μg/mL) were used starting from differentiation medium treatment. Samples were processed.
반면 지방 분해 촉진 모델에서의 평가를 위해서는 세포의 분화가 완료된 후 72시간 동안 시료를 처리하였다. 세포 배양 이후 EZ-Cytox kit의 시약을 첨가하여 2시간 동안 반응시킨 후 분광광도계(BioTek Instruments, Winooski, VT, USA)로 450 nm에서 흡광도를 측정하여 세포생존율을 확인하였다. 실험 결과는 시료 0 μM 처리군 대비 생존율로 나타냈다.On the other hand, for evaluation in the lipolysis promotion model, samples were processed for 72 hours after cell differentiation was completed. After cell culture, reagents from the EZ-Cytox kit were added and reacted for 2 hours, and cell viability was confirmed by measuring absorbance at 450 nm with a spectrophotometer (BioTek Instruments, Winooski, VT, USA). The experimental results were expressed as survival rate compared to the 0 μM sample treatment group.
표 19 및 20에서 확인할 수 있듯이, 0 부터 200 μg 농도까지 시료를 처리하였을 때 모든 시료에서 50 μg/mL 농도 처리 시부터 독성이 나타난 것으로 확인되었다.As can be seen in Tables 19 and 20, when samples were treated from 0 to 200 μg concentration, it was confirmed that all samples showed toxicity starting from the treatment at 50 μg/mL concentration.
따라서 이후의 실험은 독성이 없는 안전한 농도 범위인 40 μg/mL 이하에서 진행하였다.Therefore, subsequent experiments were conducted below 40 μg/mL, which is a non-toxic safe concentration range.
4-2. 지방 생성 억제 효과의 확인4-2. Confirmation of the effect of inhibiting lipogenesis
시료의 지방 생성 억제 효과를 확인하기 위해 oil red o staining을 진행하였다. 24 웰 플레이트에 2 X 104 cells/well로 총 용적이 1 mL이 되도록 세포를 분주한 후 지방세포로 분화시킴과 동시에 시료를 처리하였다. 이때 시료의 농도는 상기 실시예 4-1에서 세포 독성 평가 결과 독성이 나타나지 않은 안전한 범위 내에서 진행하였다.Oil red o staining was performed to confirm the effect of inhibiting lipogenesis in the sample. Cells were distributed in a 24- well plate at 2 At this time, the concentration of the sample was conducted within a safe range that did not show toxicity as a result of the cytotoxicity evaluation in Example 4-1.
또한 양성 대조군(positive control)으로써 에피갈로카테킨 갈레이트(Epigallro Catechine Gallate; EGCG)를 사용하였다. 분화 완료 후 세포를 1X PBS로 한 번 세척(washing)하고 10% 포르말린(formalin)을 1 mL 첨가하였다. 30분간 반응시킨 다음 PBS로 두 번 세척하고 oil red o solution (0.2 g/100 mL isopropranol)을 첨가하여 1시간 반응시켰다.Additionally, Epigallocatechin Gallate (EGCG) was used as a positive control. After differentiation was completed, the cells were washed once with 1X PBS and 1 mL of 10% formalin was added. After reacting for 30 minutes, the reaction was washed twice with PBS, oil red o solution (0.2 g/100 mL isopropranol) was added, and reaction was performed for 1 hour.
PBS로 두 번 세척한 후 H2O를 넣고 현미경(Nikon, Tokyo, Japan)으로 관찰하였다. 관찰 후 H2O를 제거하고 완전히 건조한 후 0.5 mL의 이소프로판올(isopropanol)을 첨가하여 30분 반응시키고 510 nm에서 분광광도계로 흡광도를 측정하였다.After washing twice with PBS, H 2 O was added and observed under a microscope (Nikon, Tokyo, Japan). After observation, H 2 O was removed, completely dried, and 0.5 mL of isopropanol was added, reacted for 30 minutes, and absorbance was measured with a spectrophotometer at 510 nm.
도 15에서 확인할 수 있듯이, 세포 독성이 없는 안전한 농도 범위인 40 μg 이하의 농도 범위에서 실험을 진행하였을 때 청유자와 황유자 분말 모두 무처리군에 비해 KN 효소 또는 NYO2 균주 배양 상등액 처리군에서 지방세포로의 분화가 감소된 것으로 확인되었다. 이는 Oil red O로 3T3-L1을 염색시킨 세포 사진에서도 확인이 가능했다.As can be seen in Figure 15, when the experiment was conducted at a concentration range of 40 μg or less, which is a safe concentration range without cytotoxicity, both green citron and yellow citron powder were converted to adipocytes in the KN enzyme or NYO2 strain culture supernatant treated group compared to the untreated group. It was confirmed that differentiation was reduced. This could also be confirmed in photos of cells stained with 3T3-L1 with Oil red O.
표 21, 도 16a 및 16b에서 확인할 수 있듯이, 청유자는 황유자에 비해 지방세포 분화 억제 효과가 더 뛰어났는데, 특히 NYO2 균주 배양 상등액 40 μg 처리군에서 가장 효과적으로 전지방세포의 분화를 억제하였다. 따라서 본 실험 결과 Con, KN 효소 또는 NYO2 균주 배양 상등액 처리군 모두가 전지방세포의 지방세포로 분화를 억제함으로써 지방 생성 및 축적을 억제할 수 있을 것이라 사료되었다.As can be seen in Table 21 and Figures 16a and 16b, green citron had a more excellent effect of inhibiting adipocyte differentiation than yellow citron. In particular, it most effectively inhibited differentiation of preadipocytes in the group treated with 40 μg of NYO2 strain culture supernatant. Therefore, as a result of this experiment, it was believed that all groups treated with Con, KN enzyme, or NYO2 strain culture supernatant would be able to suppress fat production and accumulation by inhibiting the differentiation of pre-adipocytes into adipocytes.
4-3. 유리 글리세롤 분석을 통한 지방 분해 촉진 효과 분석4-3. Analysis of the effect of promoting lipolysis through free glycerol analysis
중성지방은 글리세롤 한 분자와 지방산 세 분자가 결합하고 있는 형태로, 중성지방이 분해된 후 지방산은 중성지방의 재합성에 이용되는 반면 글리세롤은 세포 외 혈액으로 유리되어 간으로 이송된다. 따라서 전지방세포에서 유리된 글리세롤 함량을 통해 지방 분해 촉진 효과를 간접적으로 확인하고자 하였다.Neutral fat is a combination of one glycerol molecule and three fatty acid molecules. After neutral fat is broken down, the fatty acid is used to resynthesize neutral fat, while glycerol is released into the extracellular blood and transported to the liver. Therefore, we sought to indirectly confirm the effect of promoting lipolysis through the glycerol content released from pre-adipocytes.
시료의 지방 분해 촉진 효과를 확인하기 위해 유리 글리세롤 분석(free glycerol assay)을 진행하였다. 24 웰 플레이트에 2 X 104 cells/well로 총 용적이 1 mL이 되도록 세포를 분주한 후 지방세포로 분화시켜 시료를 처리하였다. 이때 시료의 농도는 이전 세포 독성 평가 결과 독성이 나타나지 않은 안전한 범위 내에서 진행하였다.Free glycerol assay was performed to confirm the effect of promoting lipolysis of the sample. Cells were distributed in a 24- well plate at 2 At this time, the concentration of the sample was within a safe range that did not show toxicity as a result of previous cytotoxicity evaluation.
분화 완료 후 세포 상층액을 수집하여 EZ-free glycerol assay kit로 제조사의 실험 방법에 따라 유리 글리세롤 함량을 측정하였다. 실험 결과는 무처리군 대비 유리 글리세롤 방출량으로 나타냈다.After differentiation was completed, the cell supernatant was collected and the free glycerol content was measured using an EZ-free glycerol assay kit according to the manufacturer's experimental method. The experimental results were expressed as the amount of free glycerol released compared to the untreated group.
표 22, 도 17a 및 17b에서 확인할 수 있듯이, 모든 시료에서 무처리군에 비해 유리된 글리세롤 함량이 높은 것으로 나타났다. 특히, 앞선 Oil red O 실험 결과와 마찬가지로 청유자에 대한 NYO2 균주 배양 상등액 40 μg 처리군에서 가장 효과적으로 유리 글리세롤이 증가한 것으로 확인되었다. 따라서 청유자, 황유자에 대한 KN 효소 또는 NYO2 균주 배양 상등액 처리군 시료 모두가 중성지방을 분해하는 지방 분해 촉진 효과를 가졌으며, 그 중 특히 청유자에 대한 NYO2 처리군 시료에서 그 정도가 뛰어날 것이라 예상되었다.As can be seen in Table 22 and Figures 17a and 17b, the free glycerol content was found to be higher in all samples compared to the untreated group. In particular, as with the results of the previous Oil red O experiment, It was confirmed that free glycerol increased most effectively in the group treated with 40 μg of NYO2 strain culture supernatant for Cheongyuja. Therefore, all samples from the KN enzyme or NYO2 strain culture supernatant treatment groups for green citron and yellow citron had a lipolysis-promoting effect that decomposes neutral fat, and it is expected that the effect will be especially excellent for the samples from the NYO2 treatment group for green citron. It has been done.
4-4. 지방산 합성 효소 함량의 ELISA를 통한 지방 생성 억제 효과 분석4-4. Analysis of lipogenesis inhibition effect through ELISA of fatty acid synthase content
지방산 합성 효소(Fatty acid synthase)는 장쇄지방산의 합성을 촉매하는 효소로써 중성지방의 합성에 필수적인 효소이다. 따라서 분화된 전지방 세포에 효소처리된 유자 시료를 처리 후 각세포에서 함유하고 있는 지방산 합성 효소 함량을 조사하여 효소의 감소된 함량을 통한 지방 합성 억제 효과를 확인하고자 하였다.Fatty acid synthase is an enzyme that catalyzes the synthesis of long-chain fatty acids and is essential for the synthesis of neutral fats. Therefore, after treating enzyme-treated citron samples with differentiated pre-fat cells, the fatty acid synthesis enzyme content contained in each cell was investigated to confirm the effect of suppressing fat synthesis through the reduced content of the enzyme.
시료의 지방 생성 억제 효과를 확인하기 위해 지방산 합성 효소의 양을 ELISA로 측정하였다. 6 웰 플레이트에 1 X 105 cells/well로 총 용적이 4 mL이 되도록 세포를 분주한 후 지방세포로 분화시킴과 동시에 시료(20 μg/mL)를 처리하였다.To confirm the effect of inhibiting lipogenesis in the sample, the amount of fatty acid synthase was measured by ELISA. in 6 well plate 1 After dispensing cells to a total volume of 4 mL, they were differentiated into adipocytes and treated with samples (20 μg/mL).
이후 세포를 모아 RIPA 버퍼(buffer)로 세포을 파쇄(lysis)하여 균질화하고 얼음(ice)에 보관하며 실험에 사용하였다. ELISA용 96 웰 플레이트의 각 웰에 표준(standard) 물질과 시료를 100 μL씩 분주하여 37℃에서 2시간 반응시킨 후 상층액을 제거하고 100 μL의 바이오틴-검출 항체(biotin-detection antibody)를 각 웰에 첨가하였다. 37℃에서 1시간 반응시키고 세척 버퍼(washing buffer)로 세척 후 100 μL의 HRP-avidin을 첨가하여 1시간 처리했다.Afterwards, the cells were collected, lysed with RIPA buffer, homogenized, stored on ice, and used in experiments. Dispense 100 μL of standard material and sample into each well of a 96-well plate for ELISA, react for 2 hours at 37°C, remove the supernatant, and add 100 μL of biotin-detection antibody to each well. added to the well. Reaction was performed at 37°C for 1 hour, washed with washing buffer, and 100 μL of HRP-avidin was added and treated for 1 hour.
세척 후 90 μL의 TMB 기질(substrate)을 15분간 반응시킨 후 50 μL의 정지 용액(stop solution)을 넣고 살짝 혼합하여 450 nm에서 흡광도를 측정하였다. 또한 균질화한 세포핵에 브래드포드 시약(bradford reagent)을 첨가하여 15분간 반응시키고 595 nm에서 흡광도를 측정한 후 BSA를 표준 커브(standard curve)로 하는 계산식에 대입하여 pg/mg protein으로 나타냈다.After washing, 90 μL of TMB substrate was reacted for 15 minutes, then 50 μL of stop solution was added, mixed gently, and absorbance was measured at 450 nm. In addition, Bradford reagent was added to the homogenized cell nuclei, reacted for 15 minutes, absorbance was measured at 595 nm, and it was expressed as pg/mg protein by substituting BSA into the calculation formula using the standard curve.
표 23 및 도 18에서 확인할 수 있듯이, 모든 시료에서 무처리군에 비해 유의적으로 지방산 합성 효소의 함량이 감소하였고, 무처리군, KN 처리군, NYO2 처리군 순서로 효과적인 것으로 나타났다. 따라서 본 실험 결과를 oil red O 실험 결과와 종합하였을 때, 시료가 지방산 합성 효소의 발현을 감소시킴으로써 지방의 합성 및 축적을 억제할 수 있을 것이라 판단되었다.As can be seen in Table 23 and Figure 18, the content of fatty acid synthase was significantly reduced in all samples compared to the untreated group, and the untreated group, KN-treated group, and NYO2-treated group were found to be effective in that order. Therefore, when the results of this experiment were combined with the results of the oil red O experiment, it was determined that the sample could inhibit the synthesis and accumulation of fat by reducing the expression of fatty acid synthase.
대조군(179 pg) 대비 청유자 및 황유자의 지방산 합성 효소 함량은 무처리군에서 74%(133 pg)로 감소하였으며 청유자의 경우 KN(116 pg), NYO2(106 pg), 황유자는 KN(130 pg), NYO2(102 pg)으로 황유자에서 효소처리된 NYO2 처리군 분말이 57%의 지방 분해 효소를 가장 낮게 함유하고 있었다.Compared to the control group (179 pg), the fatty acid synthase content of green citron and yellow citron decreased by 74% (133 pg) in the untreated group, with KN (116 pg) and NYO2 (106 pg) for green citron and KN (130 pg) for yellow citron. ), the NYO2-treated group powder, which was enzyme-treated from yellow citron with NYO2 (102 pg), contained the lowest amount of lipolytic enzyme at 57%.
이상의 결과를 종합하였을 때, 청유자와 황유자에 NYO2 균주 배양 상등액을 처리한 분말은 지방 생성 억제 및 지방 분해 촉진, 지방 생성 효소의 발현의 억제에 긍정적임이 확인되었다. 또한 이외의 KN 처리군에서도 정도의 차이는 있었으나 모두 유의적인 효과를 나타냈다. 따라서 본 실험에 사용된 쓴맛이 감소된 유자 분말은 모두 지방 생성에 관여하는 효소인 지방산의 발현을 감소시켜 지방 생성을 억제하고, 중성지방의 분해를 촉진하였기 때문에, 추후 다이어트에 효과적인 소재로 개발될 수 있을 것으로 기대되었다.Summarizing the above results, it was confirmed that the powder treated with NYO2 strain culture supernatant of green citron and yellow citron was positive for inhibiting lipogenesis, promoting lipolysis, and suppressing the expression of lipogenic enzymes. In addition, there were differences in degree in the other KN treatment groups, but all showed significant effects. Therefore, all of the citron powders with reduced bitterness used in this experiment suppressed fat production by reducing the expression of fatty acids, an enzyme involved in fat production, and promoted the decomposition of neutral fat, so they could be developed as effective ingredients for dieting in the future. It was expected that it would be possible.
서열목록 전자파일 첨부Sequence list electronic file attached
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220141299A KR20240068807A (en) | 2022-10-28 | 2022-10-28 | Method for manufacturing yuzu enzyme reactant with reduced bitterness and health functional food composition for diet comprising the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220141299A KR20240068807A (en) | 2022-10-28 | 2022-10-28 | Method for manufacturing yuzu enzyme reactant with reduced bitterness and health functional food composition for diet comprising the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20240068807A true KR20240068807A (en) | 2024-05-20 |
Family
ID=91282788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220141299A KR20240068807A (en) | 2022-10-28 | 2022-10-28 | Method for manufacturing yuzu enzyme reactant with reduced bitterness and health functional food composition for diet comprising the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20240068807A (en) |
-
2022
- 2022-10-28 KR KR1020220141299A patent/KR20240068807A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105341244B (en) | Serial sorrow is escaped careless tea beverage and preparation method thereof | |
CN108157704B (en) | Antioxidant pyracantha fortuneana fruit beverage and preparation method thereof | |
KR101817282B1 (en) | Method for producing mixed barley sprout beverage with increased liver function and antioxidant activity | |
KR102387371B1 (en) | Fermented Stauntonia hexaphylla with improved antioxidant activity and uses thereof | |
CN103844299A (en) | Pomegranate beverage and preparation method thereof | |
CN1706288A (en) | Loquat juice and its production process and application | |
CN108013285A (en) | A kind of globe artichoke composite beverage and preparation method thereof | |
KR20240068807A (en) | Method for manufacturing yuzu enzyme reactant with reduced bitterness and health functional food composition for diet comprising the same | |
KR101874330B1 (en) | Production method of fermentation vinegar using balloon flower | |
KR20190076353A (en) | Method for producing stick-type beverage using Cornus officianalis with sugar coating and pressurized steaming | |
CN109275813B (en) | Method for preparing apple and berry compound pulp beverage from acanthopanax sessiliflorus pulp | |
KR20220087888A (en) | Black bellflower syrup and method of preparing therefor | |
CN111758812A (en) | Kiwi fruit tea and preparation method thereof | |
CN111587973A (en) | Preparation process of black chokeberry and ginseng composite multifunctional solid beverage | |
CN104982844B (en) | The preparation method of anthocyanin lemon tablet, anthocyanin lemon vinegar and anthocyanin lemon vinegar beverage | |
KR102559538B1 (en) | A method of oat paste with enhanced functionality | |
KR102551085B1 (en) | Konjac Bubble | |
KR102652741B1 (en) | Method for production of sweet potato syrup | |
KR101610737B1 (en) | Method for preparing Vinegar added with the Fruit of Akebia quinata having anti-oxidative, Vinegar manufactured by this method, and the functional foodcomposition comprising the same | |
KR100859750B1 (en) | The manufacture method of yacorn fermented drink | |
KR102444816B1 (en) | Preparing method of the functional rice paste using mulberry leaves, mulberry and glutinous rice | |
KR101316779B1 (en) | The making method of a thick soypaste mixed with red peppers containing a peach | |
KR102546247B1 (en) | Grapefruitcheong and Manufacturing method thereof | |
CN107821888A (en) | Tara vine fruit juice and its processing technology | |
Jeng et al. | Chemicals contents in non-alcoholic and alcoholic beverages produced from purple-fleshed and orange-fleshed sweet potato varieties |